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Impacts of an HIV Counseling and Testing Initiative:
Results from an Experimental Intervention in a Large Firm in South Africa
Yutaka Arimotoy Narumi Horiz Seiro Itoxk Yuya Kudox Kazunari Tsukadax
Abstract We have run experimental interventions to promote HIV tests in a large firm in South
Africa. We combined HIV tests with existing medical check programs to increase the uptake.
In the foregoing survey we undertook previously, it was suggested that fears and stigma of HIV/AIDS
were the primary reasons given by the employees for not taking the test. To counter these, we imple-
mented four interventions: delayed notification, opt out, risk assessment, supportive information. De-
layed notification allows one week moratorium of notification of results to curve immediate fear. Opt
out asks subjects to opt out the test if one does not to take one thereby reducing stigma of testing. Risk
assessment involves nurses to give immediate feedback on the set of questions on risky behavior to
correct beliefs about infection. Under supportive information, subjects are shown a five minute DVD
that encourages testing to reduce both fears and stigma of testing and HIV/AIDS.
Virtually no one exercised the option of delayed notification, so we used it as a control arm. We find
substantial heterogeneity in responses by ethnicity. Africans and Colored rejected the tests most often.
Supportive information increased the uptake by 6 to 16% points. We therefore conjecture that fears and
stigma of testing and HIV/AIDS were reduced to increase the uptake through supportive information
provision.
For policy purposes, we introduce the concept of detection probability using uptake and infection
probabilities. We found that, despite lower uptake rates, detection rates of seropositive cases among
African-Colored are greater than the other groups. This implies that they are of most-at-risk population
among the employees. We also found that nurse’s risk assessment tended to pick up a larger fraction of
safer individuals, thus loweing the detection rates.
Keywords HIV/AIDS, fear, stigma, randomized control trials in firms, South Africa.
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I Introduction
In rolling out HIV tests to general public, a popular approach beyond voluntary counselling and
testing (VCT) is provider initiated counselling and testing (PICT) at medical facilities. Under PICT,
a patient who visits to a health care facility for any ailment will be asked to take a test. While this
should give a good opportunity for population in need of medical care, this is likely to leave healthy
and sexually active population out of check. One potentially fruitful yet untapped source of at-risk
population can be found in the corporate sector. Employees at corporate sector are likely to have
stable and high earnings which can make them more demanded in the dating market.
We ran HIV test promotion involving randomized control trials (RCTs) in a large manufacturing
firm in South Africa. As a prepatory stage, we have conducted a survey to all employees on their
knowledge, aptitude, perception, and behavior (KAPB) on HIV/AIDS. Based on their responses,
we have identified fears and stigma as primary deterrents to test uptake. To remove stigma, we
have incorporated HIV tests in their medical surveillance program (MSP) which is mandatory for
employees with occupational health concerns. For the remainder of employees and executives, we
have instituted a simpler version of MSP, health counselling and testing (HCT), which involves tests
for chronic conditions and HIV.
We found the uptake rates among employees increased dramatically from the pre-intervention
period, yet there are limited overall impacts of experimental interventions that are intended to reduce
fears and stigma. When we decomposed the impacts by ethnicity, we found substantial heterogeneity
and interventions are uniformly less eective for Africans and Colored, the majority of population
and presumably being higher at risk. Despite the stronger test aversion by Africans and Colored, the
promotion nevertheless resulted in larger number of detection of HIV positive cases among them.
The rest of paper is organized as follows. In Section II, we review the background of HIV/AIDS
prevalence in South Africa, and in Section III existing literature on fears and stigma on HIV uptake
is discussed. In Section IV, we discuss the design of the interventions, and in Section V, we show
the results of randomization and outcomes. In Section VI, we show the estimated results and discuss
interpretations. In Section VII, we conclude and give policy recommendations.
II Background
South Africa has the largest number of People Living with HIV/AIDS in the world. According to
UNAIDS (2012), estimated 5.6 million, or 10.6% of total population, represent 23.8% of the disease
burden in sub-Saharan Africa, which makes up about a sixth of the global disease burden. In 2008,
the estimated HIV prevalence rate among adults between ages 25 and older was 16.8%. While the
national prevalence rates plateaued from 2002, the province of KwaZulu Natal, where our study site
is located, saw an increase in adult prevalence rates from 11.7% in 2002 to 15.8% in 2008 (Shisana,
O. et al. and Team, 2009).
Under the previous policy of encouraging VCT, South Africa did not achieve significant reduction
in the rate of newly infected adults. It also failed to meet the national target in cumulative HIV test
uptake, which achieved 47% between 2004 and 2009 (Table 1). In an aim to turn this tide around,
South African government introduced a new guideline on HIV counseling and testing in August,
2010. The new guideline was expanded to include a number of new components, and is characterized
by its proactive approach in reaching out the at-risk population. These components include a revision
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Table 1: Cumulative HIV test uptake, 2004 - 2009
.
.province estimated
population
target
population
number
tested
% of target
tested
Eastern Cape 6; 884; 482 2; 737; 815 1; 267; 394 46
Free State 2; 972; 983 1; 479; 942 405; 399 27
Gauteng 9; 853; 543 5; 308; 415 1; 668; 087 31
KwaZulu Natal 10; 077; 620 4; 578; 031 2; 268; 963 50
Limpopo 5; 357; 949 2; 275; 491 1; 350; 641 59
MP 3; 646; 123 1; 660; 038 739; 226 45
North West 3; 229; 078 1; 537; 093 1; 109; 242 72
Northern Cape 1; 108; 599 485; 391 282; 211 58
Western Cape 4; 945; 732 2; 203; 620 1; 481; 729 67
Total 48; 076; 109 22; 265; 836 10; 572; 892 47
Source: Table 1 of South African National AIDS Council (2010).
Note: Repeated testing by same individual is not taken into account.
Table 2: Corporate HIV/AIDS Policies
.
.countries firms HA
policy
preven
prog
VCT ART
Southern African countries 225 83 86 56 38
South Africa 96 92 91 72 41
Large (> 500 employees) 107 85   90 98 74 40
Medium (100-500 employees) 196 65   70 78 47 17
Small (< 100 employees) 691 15   20 34 15 3
Financial sector 43 81 79 60 38
Mining sector 92 60 61 57 26
Manufacturing sector 317 47 65 34 11
Transport sector 111 52 61 34 15
Motor 38 24 44 21 9
Wholesale sector 77 25 40 23 3
Construction sector 201 24 31 15 3
Retail sector 153 12 27 13 4
Source: Table 3 of Mahajan et al. (2007).
of counseling protocols as well as a shift for PICT*2 (South African National AIDS Council, 2010).
Naturally, medical facilities became the focal points of interventions.
In the new guideline, the corporate sector is given little attention. It is well known that large
firms in South Africa are complying with the legal framework for HIV/AIDS and almost all of them
have some sort of prevention programs (see Table 2).*3 In a survey conducted to major business
establishments, 81.25% of surveyed firms have HIV policies in their companies and subsidiaries
*2 Sometimes called as HIV Counseling and Testing (HCT). We avoid this terminology in this paper as we use HCT for
Health Counseling and Testing.
*3 The South African government mandates the corporate sector to provide supports to employees with HIV/AIDS care
and to protect the rights of PLWHA. In 2000, business sector also reacted to a spate of HIV infections and established
a non-profit organization (South African Business Coalition on HIV/AIDS, SABCOHA) to promote good practices
and share information.
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(Bendell et al., 2003). Corporate sector has potential advantages in rolling out HIV test.*4 Despite
its potential, little is known about the achievements and ecacy of HIV/AIDS programs in the
corporate sector.*5 To the best of our knowledge, there is no observational study with rigorous
assessment of causal impacts nor experimental evidence on corporate HIV/AIDS interventions.*6
Any policy implications from this study will be relevant and benefitial to large firms in establishing
workable program on HIV testing.
From policy makers perspectives, a program like ours should be of an interest on two grounds.
First, it is imperative for stopping the spread of the disease that the general test uptake rates to in-
crease, because self-protection and stopping contagion of HIV must start with knowing own status.
Increasing the uptake under the corporate setting is helpful as it has little overlap in targeted popula-
tion with other programs placed in medical faclities and in communities. Second, knowing the type
of interventions that is most ecient in detecting HIV positive cases, or the detection rates, should
be benefitial in formulating policies. Detection rate, defined as the number of HIV positive cases
found among the number of people who were oered a test, is a useful indicator for policy makers
under a limited resource setting where one must pick the most eective tool in detecting the HIV
positive cases. We will therefore also consider not just the uptake rates but also the detection rates
under each treatment arms.
III Existing literature
In 2009, we have conducted interviews to all employess in the Company on their knowledge, apti-
tude, perception, and behaviours (KAPB). We have found that employees cite intrinsic fears towards
disease (Deblonde et al., 2010; Jurgensen et al., 2012) and stigma to be the major deterrents to test-
ing (Arimoto et al., 2012). We have taken these evidence seriously and designed our experimental
*4 Most of advantages of corporate sector interventions originate from the facts that there are many, prime age people in a
firm and that it is a structured organization. Ease of access to individuals, structured and functioning lines of command
to allow eective implementation and follow up, availability of medical infrastructure (on site) and personnel who
will be responsible for the program, availability of pre-existing information on individuals to fine-tune intervention
design, assurance given to individuals on the availability of treatments, assurance of job security (under an assumption
of adherence to rule of law), and financial stability are such examples. This obvious upside is accompanied with dis-
advantages that are usually found in a corporate society. They are: a tightly knit community that will make anonymity
dicult to assure, history of organizational disputes that can impede eective communications among managers and
employees, fear of corporate punitive actions toward PLWHA, possible negative short term impacts on productivity,
reluctance/sabotage by the personnel who fear additional workload and/or negative evaluations in the case of failure
(See the Adam eect in List, 2011).
*5 When companies run programs, the experiences are rarely documented and shared publicly. Even when it is doc-
umented, it is mostly a case study which does not identify causal relationships. For example, Daly et al. (2002)
cites several corporate cases and hints causal impacts on various outcome measures without paying due attention to
identifiability of underlying parameters they are estimating.
*6 The only exception is the mining sector. Mining typically has employees to live close to the workplace, and some
employers provide lodging. This gives rise to the necessity of the employers to provide essential health care, which
includes prevention and treatments to HIV/AIDS. Mining has a peculiar advantage in oering tests and care to the
employees due to proximity of residential facilities, as they can allow outpatient visits o working hours, which can
mask the individual decisions regarding HIV/AIDS from coworkers. It is relative more advantageous than the pure
community setting interventions as the corporate structure allows them to achieve better adherence of drug regimen.
Given that the rest of the corporate sector does not enjoy the advantage of work-home proximity, in addition to rela-
tively small weight of the mining sector in terms of labor force (6.2% of all employment at the end of third quarter of
2011 (Africa, 2011), HIV/AIDS promotion experience under non-mining setting will help South African corporates
as an important source of reference.
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interventions to reduce fears and stigma.
There are several influential studies that set out the definitions of stigma. Van Brakel (2006) shows
that previous works focused on measurement have dealt with the following HIV stigma categories:
(1) discrimination incidence, (2) attitude toward PLWHA, (3) institutional practices, (4) perceived
stigma. After the literature search (see Appendix A for the summary), we adopt UNAIDS (2003)’s
definition and its explanation to be most straightforward, inclusive of all four categories in the above,
and relevant under our context: “a process of devaluation of people either living with or associated
with HIV and AIDS”. As fear is relatively understudied, we will devise our own working definition:
“Reluctance or aversion to face the disease (even in isolation of social repercussions)”.
Economic literature closely related to stigma can be found in the analysis of “acting White” by
Austen-Smith and Fryer (2005); Fryer and Torelli (2010). In it, the costs of acts against peer group
acceptance alters individual actions, resulting in suboptimality.*7 By analogy, to maintain peer group
acceptance by not showing connections with HIV/AIDs, individuals may choose not to get tested for
HIV/AIDS even if they know that it is meritous.
There is a good load of studies that blame stigma as the root cause of low uptake rates of HIV
tests. Impacts of stigma is not clearly identified in the previous literature, despite its popularity in
concepturization (Berger et al., 2001; Bendell et al., 2003). This is because stigma is dicult to
measure, and this makes it also dicult to establish the causal relationship on uptake. In measuring
stigma, previous studies have relied on descriptive assessment or self-reported feeling of stigma in
the questionnaire, typically in Lickert scales (Berger et al., 2001; MacQuarrie et al., 2009). While
these self-reported measures are informative, they are ordinal in nature and cannot be used directly
as covariates in estimation.*8
Even if we can measure stigma, it is considered to suer from an omitted variable bias in esti-
mating its impacts on uptake decisions. For example, a person who is very careful may consider
the chance of being stigmatized by test taking to be large, at the same time he has a less reason to
take tests, causing a negative correlation between stigma and regression residuals, which inflates the
magnitude of estimated (presumably negative) stigma impacts, had it been regressed in the absense
of carefulness variable. It is dicult to find variables that can influence stigma but not uptake, or an
instrumental variable, in the absense of RCT. Even with an RCT, one still cannot directly measure
stigma, so one should note that any study that claims to have reduced stigma that resulted in increased
uptake rates is in fact testing for the joint hypothesis of having been able to alter stigma-reduction
factors and these factors have reduced stigma impacts on uptake.
The impacts of stigma is considered to be negative on the uptake. First line of studies use subjec-
tive information, which is subject to aforementioned limitations (Herek et al., 2003; Simbayi et al.,
2007; Kalichman and Simbayi, 2003; Mills, 2006; Wolfe et al., 2008). Impacts of fears and stigma
have rarely been examined empirically with objective data wiith an exception of Young and Ben-
david (2010). Prospective studies are also rare (Perry et al., 1991; Simpson et al., 1998; Young et
al., 2007). Simpson et al. (1998) show that a direct oer of test increases the chance of uptake but a
brief session with midwives does not. In the economics literature, Godlonton and Thornton (2012);
*7 Authors show that it alters for the people of middle ability. In equilibrium, they invest less than optimal on own human
capital.
*8 The availability of panel data allows the use of Lickert scales if estimated with ordered conditional logit model of
Chamberlain (1980). However, it requires the reported measures to be time-variant (due other than to errors in self-
evaluation). This is more plausible when stigmatizing factors change due to successful policies, but in when measured
in a short interval so introspective consistency of measures is reasonably kept.
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Ngatia (2011) give the cleanest evidence by using a randomized control trial in rural Malawi, and
find that stigma or peer pressures reduce uptake. Note that both studies do not measure stigma, so
neither of them measured the direct impacts of stigma on uptake, but a joint hypothesis as written in
the above.
Fear is relatively understudied in the context of HIV. It is suggested that receiving results also
becomes an impediment to know one’s status. In a study measuring returns for STD test results
to 258 at-risk adolescents who have voluntarily come to the clinic in Cleveland, US between 1997
and 1998, 58% choose not to return to be notified the results (Lazebnik et al., 2001). The returners
are more likely to have had private health insurance, unprotected sex while using illegal drugs and
alcohol, and previous attendance at the clinic only for HIV testing. This behaviour is consistent with
hyperbolic discounting of Ainslie and Haslam (1992); Laibson (1997), or resultant procrastination.
IV Design
IV.1 Logistics of Interventions
We have combined HIV testing and intervention to medical surveillance program (MSP) that is
currently oered to most of employees in the production line. MSP is compulsory for employees
with occupational health concerns. We combined them primarily to avoid duplications in health care
operations and minimize loss of employee time. It also had a benefit of masking employees from
their HIV test taking choices, as it is indistinguishable for casual observers and colleagues between
an employee just going for health checks and an employee receiving health checks and taking an
HIV test. However, these eects cannot be identified as we only oered HIV tests at MSP venues
for MSP eligible employees, because we did not have any other means to oer but at MSP venues.
Production lines are controlled in units called a “group”, and employee substitution is managed
by the group leaders. Group leaders are asked by the MSP coordinator to release group members,
and leaders substituted the posts of released members to keep the production line running while they
are at the clinic. Groups with fewer absence are given a priority for employee release.
For administrative employees, we have oered division-wide health-day event called Health
Counselling and Testing (HCT) that gives a chance to take HIV tests and checks for other chronic
conditions (cholesterol, blood sugar, blood pressure).*9 HCT is voluntary in nature and there is
self-selection among the target population when they participate. So we cannot interpret the esti-
mated results as the population impacts, rather, they are impacts on the sub population who agreed
to come to HCT by leaving their posts. As we will see below, there is significant self-selection in
HCT sample.
According to the agreed on schedule, each area releases employees one after another to the testing
venue. All the testing venues are on site; Company’s main, satellite, and mobile clinics for MSP-
eligible employees, and the conference rooms that are set up for HCT for MSP-ineligible employees.
Testing venues for each areas were chosen to minimize the travel distance and to control the work-
load of nurses. If the nearest clinic is too far, we used the mobile clinics. At the time we requested
cooperation to the area managers, we also encouraged to launch their own test taking campaigns in
*9 We have also spared a capacity for walk-ins who would want to get tested for chronic conditions and HIV. This is
reserved as our interventions were scheduled by areas (the unit used for plants and administrative departments), and
we found it unethical to keep the employees in areas that are scheduled at later months waited for their turn even when
they feel like to be tested immediately. Walk-in employees are tested at the main and satellite clinics.
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their area. Thus the area fixed eects in estimation also control for such dierences in area wise
eorts in promoting uptake.
At each clinic testing venue, an employee is asked to do all the routine health checks. Having
finished them, he/she is taken to a room to be oered an HIV rapid test. On supportive information
arm days, employees are shown a five minute long video that encourages testing. Employees are
always given a pretest counselling after they decided to take tests. Then a rapid test is administered
by a nurse and results are given. After the results are notified, post test counselling is given regardless
of the test outcomes.*10 Employees walk out of the room after it. We have asked nurses to give time
for employees who reject the tests, so they will stay in the room long enough that no onlookers will
know if employees have taken a test just by measuring the duration. At each HCT testing venue, the
same procedure is followed.
As we expect the dierences in employee release and uptake rates by area, it is necessary to
introduce area fixed eects in estimation. This forced us to randomize arms daily to avoid the
perfect collinearity between areas and arms. On each morning, a particular arm is announced and the
announced arm is implemented in all the testing venue for the same day. Preparations of paperwork
for the next day’s arm is done in the afternoon.
IV.2 Measures to increase uptake
Following Perry et al. (1991), we have devised an arm of supportive information under which
subjects are shown a five minute video that encourages HIV testing. In it, the CEO of the company
appears to show management’s support to the tests and treatment, a doctor explains the disease
and treatments, company’s non-discrimination policies and treatment supports through their Health
Services, and, lastly, PLWHA colleagues talk about the treatment they receive and recommend the
tests. This arm is intended to reduce both fears and stigma of HIV tests. Also, following the current
practice, we have tried the opt out arm where the default option is taking rather than not taking
the test. By changing the default option, it is assumed that test taking stigma is reduced, because
everyone else is considered to be taking the test.*11
Nurses gave feedback on the past risky behavior of subjects under risk assessment arm. These
include questions on condom use, casual sex partners, and their likeliness of getting infection. This
was intended to correct the misinformation or wrong knowledge about HIV/AIDSwhich may be held
by subjects. This can reduce or increase fear, so we instructed nurses not to magnify the fear. It can
also aect stigma as they learn more about the treatment, and we instructed nurses to reduce anxiety
about peer acceptance. So our prior on risk assessment is to reduce both fears and stigma. Note
*10 For all the positive cases, we ran confirmatory testing using Eliza whose results are notified within a week’s time.
This was done as, during the discussions with health service personnel, it was considered to be unethical not to run
confirmatory tests to positive cases on rapid tests, given that we know that it gives false positives at a very low rate.
Indeed, we did find one false positive case.
*11 One needs to be careful in the distinction between current “opt out” policies of PICT and our opt out arm. The former
contrasts hospital visitors who are oered a test and who are not. In our case, due to ethical reasons, we oer everyone
a test, but do so in a dierentiated way. What we contrast is employees who are oered a test with taking as the
default with employees who are oered a test with not taking as the default. So our “treatment” is the same with
PICT but the control is dierent. And the population will also be dierent, as hospital visitors have ailments while our
sample do not. If the population is the same, we expect smaller impacts in our interventions than under PICT, because
our control arm has been provided with stronger recommendations than PICT’s control arm. Assuming that the our
population has smaller concersn over HIV/AIDS than outpatient visitors at medical facilities, we expect the impacts
of the intervention to be even smaller.
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that DVD viewing under supportive information can be viewed as a uniform, nondierentiated way
of conveying the information to the subjects while risk assessment by the nurses is a taylor-made,
more personalized way.
As a fear can also be an impediment (Lazebnik et al., 2001; Ainslie and Haslam, 1992; Laibson,
1997; Arimoto et al., 2012), we have devised an arm to cope with procrastination of tests under
delayed notification. Under this arm, before deciding on test taking, a subject is given an option to
defer notification of results up to one week. This, in theory, can eliminate the immediate disutility
of knowing the painful truth if infected. We interpreted the prospects or anxiety over this disutility
as a fear, and expected its reduction can prompt test taking.
IV.3 Identification strategy
Given that we cannot directly measure both fears and stigma, our estimation strategy does not
seek directly to separate their impacts.*12 So we are testing a joint hypothesises that these arms can
reduce fears/stigma and can impact on uptake rates. To be precise, whatever the factors that the each
arm brings in, we refer to them as “fear”-reducing or “stigma”-reducing factors, and interpret results
as impacts of reduced fears and stigma. What we then estimate are reduced form parameters of fear-
and stigma-reducing factors. This joint hypoethsis interpretation is the same with previous research
using RCTs (Perry et al., 1991; Simpson et al., 1998; Young et al., 2007; Godlonton and Thornton,
2012; Ngatia, 2011).
We will estimate the impacts by treatment arms and ethnicity. Ethnicity is one of the focal vari-
ables in our analysis. This is because stigma and infection are both deeply rooted in social interac-
tions, and ethnicity is a key reference variable among them. When one engages in social interations,
we expect such to take place in a network of individuals rather than with a random set of individuals,
and its formation is expected to be heavily based on ethnicity. Even if one goes into a bar and has
a casual sexual relationship with a random person, we expect it to happen more frequently among
the same ethnicity than random ethnicity. As these networks are outcomes of mutual selection, the
functioning of each network is also expected to be dierent by ethnicity. We will therefore interact
treatment variables with ethnicity of subjects to see how the responses dier due to dierences in
peer group acceptance criterion.
If we denote the decision to get tested as a binary variable D = f0; 1g, then our hypothesises imply:
D =
(
0
1 if D
 = M(I; F; S t; S d)
(
6
>
0;
where I = f0; 1g is serostatus, F denotes fear, S t; S d denotes stigma of testing and HIV/AIDS,
respectively. All arguments but serostatus are suggested to reduce the uptake, hence carry negative
partial derivatives. Each experimental arms are intended to reduce each arguments.
delayed notification removes immediate psychological costs of fear by diering the notification
to the future. Stigma of testing and HIV/AIDS can be dierent if testing itself carries some psycho-
logical and physical costs such as dislike toward plicking, anxiety over talking with nurses or even
going into the testing room. Stigma of HIV/AIDS is the worry over alienation, devaluation, petty or
*12 For analytical convenience, we use the terms “fear” to refer to introspective feeling toward the disease itself apart from
any interplay with the society, and “stigma” as anything related to infection that change their relationship with the
society, but this is purely for convenience and we do not claim that we have successfully identified separate impacts of
them on uptake.
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all other forms of dierent attitudes by others due to the seropositive status. opt out can be intepreted
to remove only the stigma of testing, if any, but not the stigma of HIV/AIDS, because it does not
address anything about the consequence of test results. supportive information is intended to work
on fear, and on the stigma of testing and of HIV/AIDS, as it contains information on the disease
and on how one can work and have a life as one could have if treated properly.*13 For robustness
checks, as Simpson et al. (1998) suggest that there are important dierences by individual midwives
to the extent they can motivate the uptake, or individual midwife eects, we also control for the
nurse eects.
In addition to uptake, since we have information on serostatus for the employees who took the
test, we can construct a detection binary variable that takes the value of 1 if we observe HIV positive
case, i.e., a subject takes a test and finds a seropositive result, 0 otherwise. Detection is of an
interest to policy makers who want to know how many HIV positive cases can be found with certain
interventions.
Formally, detection is defined with two binary variates, infection I and uptake D. Given that the
detection probability is the probability of infection when D = 1, and this realizes with a probability
Pr[D = 1]. Then detection probability can be written as Pr[I = 1jD = 1] Pr[D = 1], or:
Pr[detection] = Pr[infection among test takers] Pr[uptake]:
In other words, detection probit provides no new information beyond uptake probit and infection
probits among test takers, but can concisely synthesize the findings in them. Therefore, we will
examine uptake and detection in the main text, and we will relegate infection probit estimation to the
Appendix. The above relationship shows that the detection probability is dependent on the uptake
probability of targeted group, and the infection rate or riskiness among test takers of that group. One
achieves greater detection when one successfully targets the risky group and is able to induce them
to get tested.
V Results
V.1 Balance
We used the control arm in the initial “burn-in” period to train the nurses and receptionists getting
used to the intervention protocol, in addition to a week training using mock patients. However, based
on the balance checks on the set of variates, we have found unignorable number of employee char-
acteristics that are significantly dierent between each experimental arms and the control arm. This
failure of balancing is possibly due to the fact that our control arm is concentrated at the beginning
of the campaign which might have caused to select a particular type of employees. We have thus
decided to drop all the control arm observations and use delayed notification arm as the control,
because it is spread over the entire period, and there are only 2 people who exercised the option of
delayed notification, and all other 711 people disregarded it, hence can be considered as the con-
trol.*14 In Figure 1, we show the balance tests for observable characteristics of employees. While
*13 Another possible instrument for fears is the change in prognosis, plausibly due to development of new drugs or new
treatment methods. An instrument for stigma is increased degree of confidentiality, concealment of symptoms, both
of which can result from stricter implementation of privacy protection and changes in scope for clinical suppression of
symptoms.
*14 Strictly speaking, delayed notification is a treatment so it can be dierent from the control. But if it is dierent, it is
intended to be so in the way it promotes uptake, and the uptake rate should be no smaller than the control. So the bias
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Figure 1: Contrasting Characteristics between Arms
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Notes: 1. Results of t-tests between the control (=delated notification) and each treatment arms. Grey, dark
grey, and black cells indicate statistical significance at 10%, 5%, 1% levels, respectively.
2. Variables are as follows: age (age of subjects), wrkyrs (years at company), hourly (hourly
paid worker), bmi (body mass amongdex), risk assess1 (subjective probability of amongfection),
lyears (correct answer to HIV longevity question), ”STI times (number of past STI), hep mal tb
(amongfected with hepatitis, malaria, tubercrosis), relatives pos (HIV positive among relatives),
friends pos (HIV positive among friends), colleagues pos (HIV positive among colleagues), rela-
tives died (HIV related deaths among relatives), friends died (HIV related deaths among friends),
colleagues died (HIV related deaths among colleagues), HCT before (done HCT before), med aid
(have medical insurance), spouses sex people (number of spouses with sexual relationship),
bf gf sex people (number of boy/girl friends with sexual relationship), other sex people (num-
ber of other partners with sexual relationship), all sex people (total number of people with sexual
relationship).
there are some significant dierences, most notably in BMI, Whites and others, being medical aid,
and number of sex partners in boy friends and girl friends, most of other characteristics are insignif-
icantly dierent from each other. To account for observable dierences, we added these variables as
controls in the estimation, most of which turned out to be statistically insignificant.
V.2 Sample
Intervention began in October, 2010 and ended in February, 2011. Total of 3330 people were
oered a chance to take HIV tests. Among which, 28 came as a walk-in which we dropped from our
analysis. We further dropped 1 observation with missing route (either MSP or HCT), 18 observation
with missing ethnicity, 2 observations with missing hivtest. Then we are left with the total of 3281
observations, among which 1771 are from MSP route that are prepared for employees with potential
introduced in the use of delayed notification as control should be underestimation of the impacts of other treatment
arms. So our estimates are conservative in this regard with unedrestimation biases.
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industrial health hazards. After dropping the entire control arm, 510 observations, we have 2771
observations, of which 1442 are from MSP route.
One concern about the measurement of uptake rates is that there may be individuals who already
know their seropositive status and may or may not take tests. This gives a noise to our estimation,
and we do not know the direction of the bias it may cause. To make interpretation of estimates
straightforward, we drop the suspect cases. Since we could not legally ask the serostatus, we need
to use an algorithm to screen out cases who already know their seropositive status (known-to-self
seropositive cases). Using information in data set related to serostatus, we can come up with three
tiers of criterion: (1) rejects testing by saying that one is already on a treatment (36 observations),
(2) rejects testing by saying that one is sure about status and participates in the prevalence study*15
that results in a positive test result (13 observations), (3) rejects testing by saying that one is sure
about status and claims that subjective probability of infection is 100% (51 observations). We regard
(1) and (2) to be the most reasonable criterion and use them in our main results. Criteria (3) may
include cases who knows their seropositive status, but we suspect it also includes an unignorable
number of cases who hesitate to know their serostatus despite their convitions. In the Appendix, we
show that estimated results of interventions under criterion (3) do not change qualitativey.*16
Applying criteria (1), MSP and HCT sample size are 1412, 1323, respectively, applying (2) gives
1404, 1318, and applying (3) yields 1361, 1310. As stated in the above, we will use for the main
analysis the sample with criterion up to (2) with 2722 sample size.
Table A2 gives the descriptive statistics of the 2722 observations that we use in our main analysis.
In the descriptive statistics of TableA2, we have 51.6% inMSP and remaining 48.4% in HCT sample.
African-Colored are the majority ethnic group with 65.5%, and the White-Other (East Asians) are
the smallest group at 10.1%.*17 Median age is 36, with 40.4% is single, and sample is predominantly
male with 80.2%. 54.2% are the hourly paid employees, and median years with the Company is 7.
These indicate that the demography of sample to be highly sexually active.
On average, the sample has the median of two armative answers to ten STD screening questions
that are standardly used in medical practices. The incidence of having PLWHA in relatives, friends,
and colleagues are similar to the incidence of HIV/AIDS deaths. With screening out criterion up
to (2), the median subjective probability of HIV infection is 0%, with the mean at 16.8%. The
same numbers under criteria (1) are 0% and 17.1%, under criterion up to (3) are 0% and 15.1%,
respectively.
Regarding relationships, 24.2% reports the sexual relationship with multiple partners in the last
12 months, and 6.5% has partner concurrency. South African National AIDS Council (2010, Table
3.15) gives ratio of multiple sexual partnership in the last 12 months among the sampled individuals
aged 15-49 that is significantly lower at 10.6% for national average and 10.2% for KwaZulu Natal
average. The information on partner concurrency is unique to this data set and there is no comparable
information in other data set. Therefore it is dicult to evaluate this number, but we believe the mean
ratio of individuals with partner concurrency to be also higher than the KZN average. So we may
be looking at potentially riskier population than the rest of KZN, which may be due to having more
*15 A prevalence study collects anonymous blood sample from individuals and test to estimate population prevalence of
the disease.
*16 In the earlier version of the paper, we show the results do not change if we do not drop suspect cases.
*17 In MSP, sample size of Colored are 50 while Africans are 671, it is clear that we need to work on increasing the
uptake rates among the Africans. As the number of Colored are small and uptake is highly correlated with Africans,
we integrate Colored and Africans in estimation to increase eciency. We have tried separate grouping but wound up
having grossly imprecise estimates for the Colored.
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Figure 2: Daily uptake rates and number of visitors by day
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stable and better paid jobs that would make them more demanded in the dating markets. This is not
surprising as the prevalence rates of HIV/AIDS are reportedly higher among the wealthier cohorts
in South Africa (Ba¨rnighausen et al., 2007; Gillespie et al., 2007).
V.3 Uptake
As shown in Table 3, we targeted 2392 empoyees in HCT and 1860 employees in MSP. Among
which, 1519 (63.5% of HCT target) and 1782 (95.8% of MSP target) in MSP individuals partici-
pated to the respective medical programs, total of 3301. After dropping observation with missing
information, walk-ins, the original control arm, and known-to-self seropositive cases, each sample
size is reduced to 1318 and 1404, total of 2722 that we use in our main analysis. Based on these
2722 observations, the number of uptake of HIV test are 1236 (93.8% ) and 1017 (72.4%).
Since MSP is compulsory while HCT is not, the compliance rate among HCT sample is lower
than MSP sample. This indicates significant self-selection to the company medical program among
admistrative workers. Given we could not interview employees who did not comply, we have no
way to infer the selection process. The overall uptake rate of 82.8% is considered to be a major
improvement from the unocial estimate of 49% uptake rate of KAPB survey conducted in 2009,
before the intervention (Arimoto et al., 2012).*18 Daily uptake rates in Figure 2 vary by date, and
follow an inverse-U type curve. This is likely to be induced by the hype toward the World AIDS
Day on December 1st and its gradual tapering o afterwards.
The uptake rates do not vary much by arm as shown in Table 4. Using a chi-squared test, the
null hypothesis that all proportions are equal is not rejected (p value .447). As an overall average
treatment on the treated (ATT) estimator without any control covariates, we reject the impacts of
*18 If we retain the original control in our sample, the uptake rate becomes even higher as the orginal control arm has a
higher uptake rate.
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Table 3: Sample Selection Process
.
.
.
hct msp total
targeted 2392 1860 4252
complete and complied 1510 1771 3281
(of targeted) (63.13%) (95.22%) (77.16%)
dropped control 1329 1442 2771
(of complete and complied) (88.01%) (81.42%) (84.46%)
non-positive 1318 1404 2722
(of dropped control) (99.17%) (97.36%) (98.23%)
uptake 1236 1017 2253
(of non-positive) (93.78%) (72.44%) (82.77%)
positive 38 58 96
(of uptake) (3.07%) (5.70%) (4.26%)
Notes: 1. “complete and complied” indicates the number of employees whose in-
formation in data set is complete for analysis and who have come to the
designated testing sites.
2. “dropped control” indicates the number of observations that are left af-
ter dropping the original control group due to severe lack of balance
with experimental arms.
3. “non-positive” indicates the number of observations that are left after
applying the criterion up to (2) that are intended to screen out known-
to-self seropositive cases.
Table 4: Uptake by Arms
.
.
.
yes no uptake
control 574 129 0:817
opt out 543 125 0:813
risk assessment 518 98 0:841
supportive information 618 117 0:841
total 2253 469 0:828
Notes: 1. A ratio is a fraction of uptake in total.
2. A null hypothesis that all five ratios to be equal is not rejected with
p = 0:447 using a 2 test. Other tests give similar results.
interventions on uptake, indicating overall ineectiveness of each experimental arms in comparison
to the control arm. This is not surprising because it was found in Arimoto et al. (2012) that fears and
stigma are felt by a particular group of individuals, not everyone.
The uptake rates are found to vary by ethnicity, however. In Figure 3, we plot the mean uptake rates
by arms and ethnicity, which we classify into African-Colored, Indians, and White-Others.*19 This
shows that Indians are taking tests at above 95% rates under any arm, and Whites and Others are
also taking at high rates. African-Colored show the lowest uptake rates under all arms. Although
variations between each experimental arms vis-a-vis the control arm are not uniform across ethnic-
ity, we see a general small increase under supportive information over the control. This suggests
that we can expect supportive information arm to yield small positive impacts after controlling the
observables, and a better fit of estimation if we interact arms with ethnicity.
If we further divide the sample into MSP and HCT, we see that African-Colored in MSP sample
have particularly low uptake rates. In Figure 4, we plotted the uptake rates for all arms and ethnicity
by route. We see that HCT sample has high uptake rates across all ethnicity and arms, which is
consistent with the fact that selection has already taken place at participation to HCT. InMSP sample,
Indians and White-Others are recording high rates but African-Colored have substantially lower
*19 Others are mainly Japanese.
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Figure 3: Uptake Rates by Ethnicity and Arms
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Figure 4: Uptake Rates by Ethnicity, Arms, and Route
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rates. Indians are in particular showing a stable pattern across arms and routes.*20 In Figure 4, we see
a weakly increasing pattern in all the ethnicity of MSP sample, indicating supportive information
arm had the largest impacts. We do not observe such a pattern in HCT sample. These observations
suggest that we would expect to find impacts of each arms among MSP sample but not in HCT
sample.
VI Estimation
In this section, we estimate the uptake probability using probit models. We use as covariates the
individual characteristics, work related characteristics, work area dummies, anthropometrics, risk
related information, subjective probability and experimental arm dummies. Since the only covariates
that are legitimately thought as exogenous are ethnicity, we consider other covariates as controls, and
would not try to draw causal interpretations from them. As seen in the previous section, the impacts
may vary by ethnicity. Hence we will interact ethnicity with experimental arms. Default category of
ethnicity is Indians. All interacted terms are demeaned.
*20 These are the perfect candidates for the choice of default in creating dummy variables in estimation.
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VI.1 Uptake
The results of estimated marginal eects on uptake probabilities are shown in Figure 5 for MSP
sample and Figure 6 for HCT sample. Estimation results on which these figures based are presented
in Table 5 and Table 6. Three panels show arm level estimates, sum of African-Colored level estimates
and cross estimates of African-Colored and arms, and sum of White-Others level estimates and cross
estimates of White-Others and arms. We compute the sum of level and cross estimates by adding
cross marginal eects and ethnicity level marginal eects, or opt out  africans / colored +africans / colored in
the case of cross marginal eects of African-Colored under opt out arm.
As we have seen in the previous section, impact heterogeneity is visible by ethnicity and by route.
In Figure 5, we confirm our exploratory analysis that supportive information in the MSP sample (arm
level estimate with Indians as reference ethnicity) is weakly increasing the uptake rate as evidenced
in the bottom left panel. Table 5 shows that supportive information has an average impact of pushing
up the uptake probability by 6 to 17 percentage points among Indians, depending on the regression
specifications. White-Others, in the top right panel, have particularly strong responses to supportive
information than their responses under the control arm that their mean (marginal increase in) uptake
probability reaches to more than 100% points. They also show positive response to risk assessment
that are weakly statistically significant in a few specifications. Thus, in relation to Simpson et al.
(1998), White-Others in our sample seemed to have responded more strongly and more uniformly
to a nondierentiated and non-personalized inducement in DVD. This also applies to Indians to
a weaker degree. African-Colored show lower uptake rates than Indians by 31 to 46 percentage
points. All experimental arms on African-Colored have statistically insignificant marginal cross
eects, hence the impacts of each arms on African-Colored are similar to those on Indians. Therefore
we expect supportive information to be eective on African-Colored.
For the HCT sample in Figure 6, we observe that each arm has almost no marginal eects in their
levels with Indians as the reference ethnicity. As also shown in Table 6, level eects of African-
Colored are negative and statistically significant in all specifications, while cross eects with arms
are no dierent from ethnicity level eects, indicating that experimental arms did not give any im-
pacts on increasing the uptake among them. Their relative uptake probabilities in ethnicity levels
are smaller than the default ethnicity of Indians by 7 to 11 percentage points. This compares favor-
ably with MSP sample whose ethnicity level estimates of African-Colored are smaller by 30 to 43
percentage points. The dierence of ethnicity impacts between MSP and HCT samples may be due
to the fact that HCT sample comprises of administrative employees who are more educated about
HIV/AIDS, and also that HCT is a self-selected sample who are more willing to take tests. White-
Others show their relative uptake probabilities to be smaller than Indians, but only those of opt out
arm are statistically significant.
In sum, joint hypothesises that our experimental arm can reduce fears and stigma, consequently
can increase uptake, are rejected for opt out, risk assessment at levels. supportive information
impacts at levels are found to be robustly statistically significant by the margin of 6 to 16% points.
This gives a clue that the stigma of HIV/AIDS may be behind the low uptake.*21
While this is encouraging, the magnitudue of its positive impacts are much smaller than the magni-
*21 Delayed notification arm that is intended to reduce fears is not eective as there are only two subjects who exercised
the delay option, hence the joint hypothesis of procrastination and fear as impediments should be considered as being
rejected. Thus fears may be considered as the reasons for test rejection, but not procrastination.
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Figure 5: Cross Marginal Impacts of Each Arms and Ethnicity, MSP Sample
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Notes 1.Estimates are from Table 5. Vertical axis represents estimated marginal change in uptake probability, horizon-
tal axis gives the regression specifications, (1) to (9). Points give the point estimates under each regression
specifications of respective arms, and bars indicate 95% confidence intervals.
2.Cluster robust standard errors are used. Clusters are area  date.
3.Under each experimental arms, estimates are computed by adding a level estimate with a cross estimate, for
example for African-Colored under opt out arm, by opt out  africans / colored + africans / colored. For the
control arm, level estimates of ethnicity impacts, say, africans / colored, are presented. All interaction terms are
demeaned.
4. Estimates of marginal impacts on uptake probabilities are computed by taking the average of probabilities @p@xi j =
nP
i=1
(0xi) j
n . Standard errors are derived with delta method.
5.Default (omitted) ethnicity category is Indians.
6.MSP sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but answers
“know about my status”, tested positive in prevalence study, and own subjective probability of infection is 1.
Figure 6: Cross Marginal Impacts of Each Arms and Ethnicity, HCT Sample
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Notes:Estimates are from Table 6. See footnotes of Figure 5.
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Table 5: Uptake Probit, MSP Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:167 1:286 1:369 1:362 1:323 1:458 1:278 1:343 1:326
(0:026) (0:188) (0:206) (0:212) (0:213) (0:235) (0:233) (0:311) (0:309)
arm (optout) 0:007 0:006 0:004 0:003 0:028 0:026 0:024 0:023 0:025
(0:034) (0:031) (0:031) (0:031) (0:045) (0:045) (0:043) (0:044) (0:044)
arm (assess) 0:061 0:049 0:045 0:043 0:060 0:059 0:053 0:041 0:042
(0:037) (0:034) (0:033) (0:034) (0:040) (0:040) (0:039) (0:040) (0:040)
arm (supp) 0:063 0:068 0:059 0:057 0:163 0:159 0:141 0:145 0:146
(0:034) (0:032) (0:032) (0:032) (0:043) (0:043) (0:040) (0:043) (0:043)
african / colored  0:432  0:411  0:407  0:409  0:394  0:314  0:300  0:303
(0:055) (0:055) (0:055) (0:057) (0:057) (0:054) (0:055) (0:055)
white / other  0:080  0:087  0:095 0:117 0:119 0:108 0:110 0:103
(0:087) (0:098) (0:097) (0:083) (0:083) (0:079) (0:082) (0:082)
age / 10  0:391  0:405  0:393  0:391  0:417  0:331  0:347  0:349
(0:093) (0:098) (0:098) (0:098) (0:107) (0:107) (0:107) (0:105)
(age / 10)2 0:050 0:051 0:050 0:050 0:052 0:042 0:042 0:042
(0:011) (0:012) (0:012) (0:012) (0:013) (0:013) (0:013) (0:013)
BMI / 10  0:036  0:031  0:031  0:033  0:035  0:040  0:041  0:041
(0:020) (0:019) (0:019) (0:019) (0:019) (0:018) (0:018) (0:018)
number of bf gf  0:020  0:019  0:019  0:019  0:005 0:002  0:002  0:002
(0:013) (0:013) (0:013) (0:013) (0:020) (0:019) (0:019) (0:019)
higher primary  0:003  0:003  0:008  0:014  0:012  0:015
(0:033) (0:034) (0:034) (0:035) (0:035) (0:035)
high school 0:016 0:018 0:011 0:003  0:020  0:026
(0:038) (0:039) (0:038) (0:039) (0:040) (0:041)
tertiary education 0:023 0:031 0:013 0:005  0:063  0:047
(0:206) (0:201) (0:211) (0:218) (0:239) (0:253)
arm (optout) * african / coloured  0:070  0:065  0:064  0:043  0:048
(0:154) (0:154) (0:147) (0:151) (0:151)
arm (optout) * white / other 0:097 0:112 0:084 0:122 0:109
(0:252) (0:251) (0:236) (0:240) (0:240)
arm (assess) * african / coloured 0:052 0:050 0:050 0:056 0:064
(0:138) (0:137) (0:132) (0:134) (0:135)
arm (assess) * white / other 0:383 0:382 0:357 0:358 0:338
(0:196) (0:195) (0:185) (0:191) (0:191)
arm (supp) * african / coloured  0:028  0:025  0:028  0:031  0:038
(0:151) (0:151) (0:143) (0:146) (0:145)
arm (supp) * white / other 1:065 1:047 0:992 0:983 0:962
(0:199) (0:197) (0:188) (0:194) (0:192)
multiple partners  0:007 0:001  0:001 0:004
(0:037) (0:037) (0:036) (0:036)
other partners 0:064 0:048 0:041 0:038
(0:047) (0:047) (0:046) (0:046)
single  0:058  0:044  0:037  0:037
(0:034) (0:033) (0:034) (0:034)
STD times  0:008  0:005  0:005  0:003
(0:013) (0:016) (0:016) (0:016)
STI screen  0:012  0:002  0:000 0:001
(0:015) (0:016) (0:016) (0:016)
TB screen  0:008  0:005  0:004  0:005
(0:008) (0:008) (0:008) (0:008)
subjective probability  0:253  0:257  0:257
(0:045) (0:045) (0:045)
days since HCT began / 100 0:085 0:055
(0:346) (0:347)
(days since HCT began / 100)2  0:074  0:060
(0:147) (0:147)
hourly paid workers  0:043  0:037
(0:031) (0:031)
years at Company 0:001 0:001
(0:002) (0:002)
HCT before 0:050
(0:026)
area no no yes yes yes yes yes yes yes
pseudo R2 0:004 0:112 0:131 0:132 0:134 0:14 0:163 0:168 0:171
n 1404 1387 1387 1382 1382 1377 1294 1274 1274
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
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Table 6: Uptake Probit, HCT Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:196 0:599 0:559 0:561 0:577 0:623 0:567 0:649 0:648
(0:022) (0:147) (0:148) (0:143) (0:148) (0:155) (0:148) (0:228) (0:229)
arm (optout)  0:003 0:002  0:000  0:001 0:009 0:013 0:014 0:016 0:016
(0:021) (0:021) (0:018) (0:018) (0:019) (0:019) (0:019) (0:020) (0:020)
arm (assess)  0:014  0:007 0:008 0:006 0:004 0:004 0:002 0:007 0:007
(0:019) (0:019) (0:019) (0:019) (0:019) (0:019) (0:018) (0:018) (0:018)
arm (supp)  0:013  0:008  0:015  0:016  0:012  0:012  0:017  0:012  0:012
(0:020) (0:020) (0:022) (0:021) (0:019) (0:020) (0:019) (0:020) (0:019)
african / colored  0:080  0:105  0:106  0:110  0:101  0:072  0:070  0:070
(0:020) (0:020) (0:019) (0:021) (0:020) (0:018) (0:018) (0:019)
white / other  0:052  0:047  0:042  0:020  0:016  0:014  0:011  0:010
(0:026) (0:023) (0:023) (0:024) (0:024) (0:022) (0:021) (0:022)
age / 10  0:190  0:169  0:160  0:170  0:186  0:171  0:168  0:167
(0:073) (0:076) (0:075) (0:080) (0:083) (0:079) (0:082) (0:083)
(age / 10)2 0:024 0:021 0:020 0:021 0:022 0:020 0:019 0:019
(0:010) (0:010) (0:010) (0:011) (0:011) (0:011) (0:011) (0:011)
BMI / 10  0:015  0:010  0:010  0:009  0:007 0:000 0:001 0:001
(0:012) (0:012) (0:012) (0:012) (0:011) (0:011) (0:012) (0:012)
number of bf gf 0:007 0:001 0:001 0:002 0:003 0:007 0:004 0:004
(0:006) (0:006) (0:006) (0:006) (0:008) (0:008) (0:007) (0:007)
higher primary  0:040  0:037  0:033  0:025  0:027  0:027
(0:035) (0:034) (0:033) (0:031) (0:034) (0:034)
high school  0:001 0:000  0:002 0:003 0:002 0:002
(0:037) (0:036) (0:034) (0:032) (0:036) (0:036)
tertiary education  0:006 0:001 0:002 0:005 0:004 0:004
(0:042) (0:041) (0:038) (0:036) (0:040) (0:040)
master’s degree  0:082  0:074  0:081  0:079  0:079  0:079
(0:055) (0:053) (0:052) (0:049) (0:051) (0:051)
arm (optout) * african / coloured  0:008 0:011 0:007 0:005 0:005
(0:055) (0:053) (0:047) (0:047) (0:048)
arm (optout) * white / other  0:140  0:123  0:116  0:111  0:111
(0:062) (0:060) (0:054) (0:056) (0:056)
arm (assess) * african / coloured 0:010 0:015  0:029  0:025  0:025
(0:048) (0:047) (0:042) (0:043) (0:044)
arm (assess) * white / other  0:049  0:046  0:078  0:077  0:077
(0:064) (0:064) (0:056) (0:055) (0:056)
arm (supp) * african / coloured  0:025  0:015  0:025  0:015  0:015
(0:046) (0:046) (0:043) (0:044) (0:044)
arm (supp) * white / other  0:000 0:000  0:004  0:000 0:000
(0:062) (0:063) (0:057) (0:058) (0:058)
multiple partners 0:037 0:028 0:034 0:033
(0:023) (0:028) (0:026) (0:026)
other partners  0:013  0:007  0:013  0:013
(0:030) (0:030) (0:030) (0:030)
single  0:036  0:027  0:023  0:023
(0:016) (0:016) (0:016) (0:016)
STD times  0:012  0:006  0:006  0:006
(0:005) (0:004) (0:004) (0:004)
STI screen  0:001  0:001  0:002  0:002
(0:007) (0:008) (0:008) (0:008)
TB screen  0:007  0:004  0:003  0:003
(0:005) (0:005) (0:005) (0:005)
subjective probability  0:141  0:142  0:142
(0:026) (0:025) (0:025)
days since HCT began / 100  0:276  0:275
(0:313) (0:310)
(days since HCT began / 100)2 0:138 0:137
(0:134) (0:133)
hourly paid workers 0:003 0:002
(0:021) (0:021)
years at Company 0:001 0:001
(0:001) (0:001)
HCT before  0:002
(0:016)
area no no yes yes yes yes yes yes yes
pseudo R2 0:001 0:067 0:176 0:191 0:207 0:231 0:308 0:313 0:313
n 1318 1315 1315 1310 1310 1308 1248 1233 1233
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
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tude of impacts of ethinicity level for africans/corloured. African-Colored show consistently lower
uptake rates than Indians under any arm, and no experimental arm can counter this. All arms have
no significant cross-ethnicity impacts on increasing the uptake except for White-Others under sup-
portive information and risk assessments in MSP sample. In HCT sample, no arm has statistically
siginificant impacts in levels, due possibly to the fact that HCT is self-selected sample, while oput
out has strong negative impacts on White-Others.
As HCT sample is more of white collar and MSP sample is blue collar, we expect the educa-
tional attainment, household background, and work style dier significantly between these groups of
Africans-Coloured. In fact, when lower primary or less accounts for 21% and high school accounts
for 25% in African-Colored MSP sample, these are 8% and 39%, respectively, for African-Colored
HCT sample. Even after controlling for dierences in educational achievements, African-Colored in
MSP and HCT samples show the lower uptake rates relative to Indians, albeit less so for HCT sam-
ple. This leads us to a conjecture that the an important portion of test rejection by African-Colored
may be rooted in their ethnic institutions outside the formal institutions, not education nor job types.
Estimates on subjective probability are robustly negative on the uptake in both MSP and HCT
samples. Point estimates show that a 10% increase in subjective probability is associated with a
2.5% reduction in uptake rates in MSP, resulting in elasticity of .25, while this number is more
than halved in HCT sample. Note that variates that can be associated with riskiness such as single
and STD times are negative and statistically significant in the specification (6) of HCT sample, or
single is negative and statistically marginally significant in the specification (6) of MSP sample, they
become insignificant once we use subjective probability. This implies that subjective probability
has more direct and stronger association with unobservable riskiness than other variates. It also
gives an indication that usual STI screening questions and other risk behavioral questions may not
fully capture the unobservable risky conducts taken by the subjects. Estimates on age are negative,
as expected, because older employees may feel less in need for HIV testing. Negative estimates
on BMI in MSP sample show that more obese individuals tend to reject the tests. This may be a
reflection of general indierence toward health and/or general lack of HIV contraction risks in more
obese individuals.
VI.2 Detection
In Figure 7 and Figure 8, we plot the estimates and their 95% confidence intervals on detection
based on Table 7 and Table 8. As can be seen, African-Colored group is more at-risk and shows
positive estimates on detection. Although their uptake is lower than the others, their greater riskiness
or infection probability more than compensates for the smaller uptake probability. So one could have
achieved higher detection had we been able to induce African-Colored to get tested at a higher rate.
What is noteworthy about Figure 8 is that African-Colored among HCT sample has higher detec-
tion probabilities by 17 to 25 percentage points. While some of these numbers are smaller than their
MSP counterparts which range between 8 and 29 percentage points, they are large nonetheless if we
consider the educational attainment among HCT sample is higher than MSP sample. In Table 7 and
Table 8, we see that having finished tertiary education is strongly related to the reduction in detec-
tion. Recalling that uptake is not negative for tertiary degree holders, this is likely to be due to safer
conducts taken by this group. The protection against the disease that the school education buys is
negligible up to matriculation holders among African-Colored, suggesting their ethnic background
is still important among administrative workers with relatively higher educational attainment.
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Figure 7: Cross Marginal Impacts of Each Arms and Ethnicity on HIV Detection, MSP Sample
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Notes 1.Estimates are from Table 7. Vertical axis represents estimated marginal change in uptake probability, horizon-
tal axis gives the regression specifications, (1) to (9). Points give the point estimates under each regression
specifications of respective arms, and bars indicate 95% confidence intervals.
2.Detection binary variable takes the value of 1 if we observe HIV positive case, i.e., a subject takes a test and
shows a seropositive result, 0 otherwise.
3. See footnotes of Figure 5.
Figure 8: Cross Marginal Impacts of Each Arms and Ethnicity on HIV Detection, HCT
Sample
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Notes:Estimates are from Table 8. See footnotes of Figure 7.
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Table 7: Detection Probit, MSP Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:148  0:352  0:363  0:366  0:592  0:562  0:847  0:972  0:969
(0:010) (0:107) (0:111) (0:113) (0:123) (0:130) (0:142) (0:180) (0:183)
arm (optout) 0:003 0:005 0:007 0:007 0:006 0:008 0:008 0:005 0:005
(0:014) (0:014) (0:014) (0:014) (0:010) (0:010) (0:011) (0:012) (0:012)
arm (assess) 0:008 0:011 0:011 0:011 0:080 0:081 0:082 0:083 0:083
(0:015) (0:015) (0:015) (0:015) (0:015) (0:015) (0:016) (0:016) (0:017)
arm (supp)  0:029  0:027  0:027  0:027  0:020  0:019  0:016  0:028  0:027
(0:016) (0:016) (0:016) (0:016) (0:012) (0:012) (0:013) (0:015) (0:014)
african / colored 0:082 0:082 0:082 0:295 0:294 0:275 0:281 0:283
(0:030) (0:031) (0:030) (0:026) (0:027) (0:027) (0:027) (0:029)
white / other  0:250  0:260  0:275  0:071  0:067  0:065  0:068  0:074
(0:036) (0:036) (0:038) (0:013) (0:014) (0:014) (0:014) (0:016)
age / 10 0:063 0:058 0:056 0:056 0:037 0:016 0:012 0:010
(0:054) (0:054) (0:056) (0:057) (0:061) (0:062) (0:064) (0:065)
(age / 10)2  0:007  0:007  0:007  0:007  0:004  0:002  0:002  0:002
(0:007) (0:007) (0:007) (0:007) (0:007) (0:007) (0:008) (0:008)
BMI / 10  0:002  0:002  0:003  0:002  0:002  0:006  0:006  0:006
(0:010) (0:010) (0:010) (0:010) (0:010) (0:010) (0:011) (0:011)
number of bf gf 0:011 0:010 0:010 0:010 0:012 0:015 0:015 0:015
(0:005) (0:005) (0:005) (0:005) (0:007) (0:007) (0:007) (0:007)
higher primary 0:005 0:004 0:005  0:001 0:000  0:001
(0:017) (0:017) (0:018) (0:019) (0:020) (0:020)
high school 0:004 0:003 0:004  0:003  0:004  0:002
(0:020) (0:020) (0:020) (0:021) (0:022) (0:023)
tertiary education  0:328  0:343  0:346  0:328  0:349  0:344
(0:041) (0:042) (0:042) (0:043) (0:045) (0:045)
arm (optout) * african / coloured 0:001 0:001 0:002 0:010 0:012
(0:016) (0:017) (0:017) (0:019) (0:020)
arm (optout) * white / other  0:002  0:002 0:006 0:004 0:016
(0:017) (0:020) (0:022) (0:026) (0:029)
arm (assess) * african / coloured  0:319  0:320  0:300  0:301  0:303
(0:045) (0:046) (0:046) (0:048) (0:048)
arm (assess) * white / other  0:325  0:323  0:300  0:308  0:299
(0:047) (0:049) (0:045) (0:050) (0:053)
arm (supp) * african / coloured  0:021  0:024  0:021  0:019  0:022
(0:019) (0:019) (0:019) (0:020) (0:018)
arm (supp) * white / other 0:004 0:006 0:012 0:010 0:014
(0:021) (0:025) (0:021) (0:029) (0:032)
multiple partners  0:007  0:023  0:024  0:026
(0:018) (0:018) (0:018) (0:018)
other partners 0:003 0:011 0:013 0:014
(0:020) (0:020) (0:020) (0:020)
single  0:017  0:020  0:017  0:016
(0:018) (0:018) (0:018) (0:018)
STD times 0:003  0:002  0:002  0:002
(0:003) (0:004) (0:004) (0:004)
STI screen 0:007 0:006 0:006 0:005
(0:005) (0:005) (0:005) (0:005)
TB screen 0:001 0:002 0:002 0:002
(0:003) (0:004) (0:004) (0:004)
subjective probability 0:066 0:066 0:069
(0:019) (0:019) (0:019)
days since HCT began / 100 0:251 0:273
(0:164) (0:162)
(days since HCT began / 100)2  0:102  0:113
(0:069) (0:069)
hourly paid workers  0:008  0:010
(0:012) (0:012)
years at Company 0:001 0:001
(0:001) (0:001)
HCT before  0:022
(0:013)
area no no yes yes yes yes yes yes yes
pseudo R2 0:013 0:074 0:1 0:101 0:106 0:115 0:152 0:16 0:167
n 1404 1387 1387 1382 1382 1377 1294 1274 1274
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
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Table 8: Detection Probit, HCT Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:116  0:510  0:467  0:450  0:447  0:463  0:343  0:421  0:437
(0:008) (0:082) (0:091) (0:093) (0:093) (0:100) (0:090) (0:152) (0:158)
arm (optout)  0:005  0:004 0:001 0:003  0:001  0:004  0:002  0:002  0:001
(0:014) (0:012) (0:012) (0:012) (0:010) (0:009) (0:008) (0:009) (0:011)
arm (assess)  0:023  0:024  0:021  0:019  0:017  0:016  0:013  0:017  0:017
(0:015) (0:014) (0:014) (0:014) (0:013) (0:012) (0:011) (0:012) (0:011)
arm (supp)  0:009  0:010  0:007  0:007  0:005  0:006  0:006  0:014  0:015
(0:012) (0:012) (0:011) (0:011) (0:008) (0:009) (0:009) (0:013) (0:013)
african / colored 0:257 0:247 0:246 0:243 0:228 0:182 0:181 0:186
(0:026) (0:026) (0:029) (0:027) (0:026) (0:023) (0:024) (0:028)
white / other  0:002  0:009  0:006  0:001  0:015  0:015  0:007  0:003
(0:002) (0:030) (0:009) (0:006) (0:012) (0:013) (0:014) (0:014)
age / 10 0:081 0:073 0:065 0:065 0:071 0:025 0:013 0:021
(0:037) (0:041) (0:042) (0:042) (0:047) (0:044) (0:044) (0:044)
(age / 10)2  0:009  0:008  0:007  0:007  0:007  0:002 0:000  0:001
(0:005) (0:005) (0:005) (0:005) (0:006) (0:006) (0:006) (0:006)
BMI / 10  0:002  0:004  0:004  0:004  0:007  0:003  0:002  0:003
(0:011) (0:011) (0:011) (0:011) (0:010) (0:010) (0:011) (0:011)
number of bf gf 0:005 0:003 0:002 0:002  0:003  0:005  0:004  0:004
(0:003) (0:003) (0:003) (0:003) (0:005) (0:005) (0:006) (0:007)
higher primary 0:009 0:009 0:011 0:001 0:004 0:008
(0:017) (0:017) (0:017) (0:017) (0:018) (0:016)
high school  0:015  0:015  0:012  0:022  0:017  0:012
(0:019) (0:020) (0:020) (0:020) (0:022) (0:021)
tertiary education  0:218  0:218  0:201  0:180  0:182  0:192
(0:028) (0:028) (0:028) (0:037) (0:039) (0:040)
master’s degree 0:001 0:001 0:008 0:013 0:016 0:025
(0:024) (0:024) (0:024) (0:020) (0:024) (0:024)
arm (optout) * african / coloured 0:011 0:003 0:004 0:002  0:002
(0:021) (0:020) (0:016) (0:023) (0:029)
arm (optout) * white / other  0:010  0:009  0:019  0:024  0:006
(0:016) (0:024) (0:018) (0:025) (0:040)
arm (assess) * african / coloured  0:011  0:013  0:001 0:005  0:003
(0:021) (0:022) (0:016) (0:025) (0:028)
arm (assess) * white / other  0:019 0:004 0:009 0:010  0:004
(0:017) (0:026) (0:019) (0:028) (0:044)
arm (supp) * african / coloured  0:006  0:009 0:005 0:008 0:004
(0:015) (0:015) (0:014) (0:023) (0:031)
arm (supp) * white / other  0:001 0:018  0:003 0:002 0:013
(0:018) (0:027) (0:031) (0:031) (0:039)
multiple partners 0:002 0:003 0:001  0:001
(0:012) (0:012) (0:012) (0:012)
other partners  0:053  0:045  0:045  0:052
(0:021) (0:018) (0:018) (0:020)
single 0:027 0:019 0:016 0:012
(0:011) (0:011) (0:011) (0:011)
STD times 0:008 0:004 0:003 0:003
(0:004) (0:003) (0:004) (0:004)
STI screen 0:003 0:004 0:004 0:004
(0:004) (0:003) (0:003) (0:003)
TB screen  0:001  0:004  0:004  0:003
(0:003) (0:003) (0:003) (0:003)
subjective probability 0:063 0:064 0:065
(0:017) (0:017) (0:017)
days since HCT began / 100 0:167 0:198
(0:167) (0:172)
(days since HCT began / 100)2  0:071  0:083
(0:069) (0:071)
hourly paid workers 0:019 0:019
(0:014) (0:014)
years at Company  0:001  0:001
(0:001) (0:001)
HCT before  0:029
(0:011)
area no no yes yes yes yes yes yes yes
pseudo R2 0:009 0:191 0:241 0:257 0:257 0:295 0:349 0:36 0:386
n 1318 1315 1315 1310 1310 1308 1248 1233 1233
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
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The fact that ethnicity, education and age are readily observable, one can identify more at-risk
group by the observable characteristics. Furthermore, if one can induce them to take the tests, we
can expect a substantial number of newly found HIV positive cases. We also find that number of
boy friends and girl friends to be positively correlated with detection among MSP sample, even after
adding subjective probability and multiple partners to the covariates. This reconfirms the general
wisdom that having more number of sex partners is correlated with the risk of infection.
One also notes that, in Figure 7, detection estimates of risk assessment for MSP sample are
lower than other arms for African-Colored and White-Others. One should recall that, in Figure 5,
risk assessment for MSP sample is no less successful than other arms in inducing uptake. Then,
smaller estimates in detection reveal that nurses under risk assessment may have been trying too
hard to get the safer subjects to get tested with African-Colored and White-Others groups, or have
been ineective in inducing high risk subjects to get tested. As arm level estimates in Table 7 are
positive and significant, the overall impacts of risk assessmentwere positive in detection, but, at the
margin of African-Colored and White-Others groups, it is safer subjects who have tested more and
consequently lowered the rate of detecting the HIV positive cases among them. This is in line with
Simpson et al. (1998)’s results that confirmed heterogeneity in midwives in the extent of motivating
the individuals to get tested. At the same time, this also indicates that greater eorts by the good-
intentioned nurses can sometimes be counterproductive, as the marginal returns in detection of their
eorts are negative and could not induce the uptake of riskier subjects. This is observed only in MSP
sample and not in HCT sample. We see negative cross estimates between opt out and White-Others
in HCT sample, which is a natural outcome of smaller uptake rates in this arm-ethnicity.
VI.3 Robustness checks
We used exclusion criterion up to (3) in Table A3, Table A4 for uptake, Table A5, Table A6 for
detection. The point estimates do not dier much in all tables, and qualitative results remain the
same. In Figure A1, we plotted coecient of variation in uptake against number of subjects each
nurse faced. The curve does not seem ot show a meaningful pattern, yet, if we exclude the right
most point, it seems to indicate that uptake decision becomes more uniform once a nurse faces more
than 200 subjects. So we also used nurse fixed eects to account for dierent ability by nurses.
Since nurses are stationed in the fixed points of care, we replaced area fixed eects with nurse fixed
eects as they are perfectly collinear. Results are shown in Table A9 and Table A10. Again, results
are similar with these in the main text. For completeness sake, we also estimated infection among
the test takers, whose results are given in Table A7 and Table A8.
VII Conclusions
We have run experimental interventions in a large firm in South Africa. We combined HIV tests
with existing medical check up programs to increase the uptake. Uptake rate increased dramatically,
not only under experimental arms but also under the control arm. By ethnicity, Africans and Colored
are the groups that reject tests more. Indians are consistently showing high uptake rates. Whites and
Others have generally high uptake rates but vary by the arms. By route, MSP sample is found to
reject the test oers more often. HCT route has higher uptake rates, however, compliance to the
check up is lower than MSP sample where the latter is compulsory to take the checks.
We implemented four interventions: delayed notification, opt out, risk assessment, supportive in-
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formation. Virtually no one exercised the option of delayed notification, so we used it as a control
arm. Opt out resulted in negative impacts on uptake among White-Others in HCT sample. Risk
assessment showed marginally significant positive impacts on White-Others in MSP sample. Sup-
portive information increased the uptake of Indians and African-Colored by 6 to 16% points and
more so for White-Others. We thus find substantial heterogeneity in responses by ethnicity.
For the Africans and Colored in MSP sample, all experimental arms but supportive information
were ineective in increasing the uptake. Their responses to test oers are smallest among all ethnic
groups. This general aversion to tests among Africans and Colored is common in both MSP and
HCT samples to a dierent degree, albeit their educational background dier significantly. We
thus conjecture that factors related to their ethnic institutions other than formal institutions, such as
education or workplace, to be the important deterrents to tests.
Risk assessment by nurses resulted in lower detection of HIV among White-Others in MSP sam-
ple, and DVD viewing resulted in higher detection among African-Colored in both sample. It is
advisable not to motivate nurses to enroll more subjects to the tests, and more inpersonal DVD
viewing in an isolated room can increase the uptake.
For policy purposes, we introduced the concept of detection probability using uptake and infection
probabilities. We found that, despite lower uptake rates, detection rates of seropositive cases among
African-Colored are greater than the other groups. This applies both to MSP and HCT sample. This
implies that African-Colored are of most-at-risk population among the employees. We also found
that nurse’s risk assessment tended to pick up safer individuals, thus lowering the detection rates.
We find that subjective probability, number of boy friends and girl friends to be positively corre-
lated with detection. In addition to current practice of asking education and age, we recommend to
ask subjective probabilities and number of sex partners in targeting the most at-risk population.
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A Definitions of stigma
Fear: Reluctance or aversion to face the disease (even in isolation of social repercussions) (our
working definition).
Stigma: An attribute or a label that sets a person apart from others and links the labeled person to
undesirable characteristics (Fortenberry et al., 2002).
Stigma: As a trait, a stigma is an attribute or characteristic that is viewed negatively by the culture
or society. As an outcome, stigma occurs when the negative social meanings attached to the
discrediting attribute become linked to the individual. With that linkage the person’s social
identity changes, resulting in less than full acceptance of the person in social interaction,
identity engulfment (in which the trait becomes the defining aspect of the person, coloring all
other information about him or her), and limitation of the opportunities that would otherwise
be available (Berger et al., 2001, citing Goman (1963)’s work).
HIV-related stigma and discrimination A process of devaluation of people either living with or
associated with HIV and AIDS ... Discrimination follows stigma and is the unfair and unjust
treatment of an individual based on his or her real or perceived HIV status (UNAIDS, 2003).
If found to be HIV positive, one can expect “abandonment by spouse and/or family, social
ostracism, job and property loss, school expulsion, denial of medical services, lack of care and
support, and violence. These consequences, or fear of them, mean that people are less likely to
come in for HIV testing, disclose their HIV status to others, adopt HIV preventive behaviour,
or access treatment, care and support. If they do, they could lose everything (UNAIDS, 2007).
stigma exists if: when: “the elements of labelling, stereotyping, separation, status loss, and dis-
crimination occur together in a power situation that allows them” (Link and Phelan, 2001).
B Previous empirical research on stigma and HIV/AIDS
B.1 Measurement of stigma
Bendell et al. (2003) summarizes corporate surveys and notes that stigma and prejudice to be
the key barriers in acting on HIV/AIDS. Berger et al. (2001) cite foregoing papers and note that
concerns with stigma is widespread among PLWHA: Being rejected and fearing rejection have often
been cited as major stressors of having HIV. However, impacts of stigma is not clearly identified in
the previous literature. This is because stigma is dicult to measure, and this makes it also dicult
to establish the causal relationship on uptake.
In measuring stigma, previous studies have relied on descriptive assessment or self-reported feel-
ing of stigma in the questionnaire, all of which are subjective data (MacQuarrie et al., 2009). Stigma
is often measured with the HIV-related Stigma Scale of Berger et al. (2001). This 40-item tool has
4 sub (Likert) scales: personalized stigma, disclosure concerns, negative self-image, and concern
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over public attitudes toward PLWH.*22 All items are answered using a 4-point Likert items (strongly
disagree, disagree, agree, strongly agree).
While self-reported items and their scales are informative, they are ordinal in nature and cannot be
used directly as covariates in estimation due to diculty in interpersonal comparisons, as the latter
requires cardinality. The availability of panel data takes away the demerits in the use of Lickert scales
if used with ordered conditional logit model of Chamberlain (1980), which allows for individual
fixed eects and individual theresholds. However, it requires the scales to be time-variant (due other
than to errors in self-evaluation). This becomes more plausible when stigma reduction factors change
due to successful policies or social programs.
Even if we can measure stigma, it is considered to suer from an omitted variable bias in esti-
mating its impacts on uptake decisions. For example, a person who is very careful may consider
the chance of being stigmatized by test taking to be large, at the same time he has a less reason to
take tests, causing a negative correlation between stigma and regression residuals, which inflates the
magnitude of estimated (presumably negative) stigma impacts, had it been regressed in the absense
of carefulness variable. It is dicult to find variables that can influence stigma but not uptake, or an
instrumental variable, in the absense of RCT. Even with an RCT, one still cannot directly measure
stigma, so one should note that any study that claims to have reduced stigma that resulted in increased
uptake rates is in fact testing for the joint hypothesis of having been able to alter stigma-reduction
factors and these factors have reduced stigma impacts on uptake.
B.2 Reported causal impacts of stigma
The impacts of stigma is considered to be negative on the uptake. First line of studies use sub-
jective information. Herek et al. (2003) use US telephone interview data and find that more than
a third of respondents indicated that uptake is not going to be aected by stigma. Simbayi et al.
(2007) use Cape Town PLWHA data and find that 1/5 have lost a place to stay or job due to the
HIV status, and internalized stigma is found to have significant impacts on cognitive-aective de-
pression scores. Kalichman and Simbayi (2003), using Cape Town data, find that people who had
not been tested have a high risk of being infected with HIV, as 28% of them had a history of being
diagnosed with STDs and genital ulcers. This means that there is a group of high risk individuals
who knowingly take risks but do not get tested. Kalichman and Simbayi (2003) interpret a cause of
this rejection is due to stigma and endorse the promotion of confidentiality of testing, protection of
human rights of PLWHA, among other things.*23 In studying an informal settlement in South Africa,
Mills (2006) shows ethnographically that HIV status can be treated with particular sign languages
*22 Personalized stigma addressed the perceived consequences of other people knowing that the respondent has HIV, such
as losing friends, feeling that people were avoiding him/ her, and regrets for having told some people. Disclosure
concerns are related to controlling information, such as keeping one’s HIV status secret, or worrying that others who
knew the respondent’s HIV status would tell. Negative self-image is feelings of shame and guilt, including feeling
unclean, not as good as others, or like a bad person because of HIV. Concern over public attitudes toward PLWH
includes what “most people” think about a person with HIV or what “most people” with HIV can expect when others
learn they have HIV, and includes discrimination and employability.
*23 Our finding from the project is broadly in line with them, but goes further beyond that these two may not suce.
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and social downward mobility, all of which keep individuals from seeking care at local clinics. In
neighboring Botswana, Wolfe et al. (2008) suggests that 40% of patients on ART delayed testing,
mostly due to stigma. These studies are suggestive yet make use of subjective information which
limits its capacity to be accepted as scientific evidence.
Impacts of fears and stigma have rarely been examined empirically with objective data. An excep-
tion is Young and Bendavid (2010) who found from US out patient visit data a positive correlation
between HIV testing and use of unrelated tests, and between HIV testing and HIV as a secondary
reason for visit rather than first. They interpret their results that individuals seeking HIV tests look
for a cover to avoid stigma. While we believe their interpretation is highly likely, as they note, it
is a correlation not a causal relationship. In particular, the reverse causality of “multiple testing )
HIV/AIDS testing” arises when the unhealthy people get various ailments including HIV/AIDS.
In a rare prospective study, Perry et al. (1991) use video sessions on 1,307 physically asymp-
tomatic adults in the US and assessed their impacts on emotional distress scaled by five standardized
distress measures at entry and 3 months later. They found that video sessions reduced emotional
distress of HIV negative subjects but no impacts on HIV positive subjects, while stress prevention
training reduced stresses on both seronegative and seropositive subjects. Simpson et al. (1998) of-
fered HIV tests on pregnant women at antenatal clinics with randomized length of discussions with
midwives and randomized contents of leaflets. Subjects under the treated arms, or those who had
discussed with midwives or had been exposed to leaflets, had higher uptake rates between 31.6%
to 37.0% compared to 5.5% of control arm. There was no statistically significant dierence among
the treated arms. Young et al. (2007) have conducted a series of lab experiments on a group of
undergraduate students at Stanford. Their study is of interest as it focuses on how non-stigmatized
people react to HIV stigma when they are stigmatized. They found that adding unprotected sex, a
source of stigma that being immoral, to a list of potential causes of disease reduces the likelihood of
individuals requesting a test, which is considered to be due to stigmatization, although the sample
size is small (36).*24
In the economics literature, Godlonton and Thornton (2012) use a randomized control trial that
distributes cash incentives to get tested and estimate the net impacts of peer group eects. The peer
group is assumed to be neighbors, and thus is treated as exogenously given in their estimation. To
deal with the reflexion problem of (or a matching-induced correlation between) peer groups with
oneself, they use cash incentive amounts of neighbors as an instrumental variable for neighbor’s
test taking experiences. They find the elasticity of peer eects on test uptake to be 0.11, and some
suggestive evidence of retardation of intrinsic incentives through peer eects. Ngatia (2011) captures
all important social networks by each resident in rural villages and estimate their peer eects on
uptake. She assumes the stigma is larger for individuals whose neighbors get tested for smaller
cash incentives, and finds stigma reduces uptake. This literature considers the important question of
*24 This is in line with conjunction fallacy that Tversky and Kahneman (1983) posited, as adding a cause decreased the
chance, which is a violation of the probability axiom. In their experiments, fear is controlled to be the same between
the case with and without unprotected sex as a potential cause of disease, because the disease they reveal to the subjects
is the same.
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whether extrinsic incentives undermine the intrinsic incentives, however, this topic is out of scope
of our paper. Both studies have not tested for impacts of stigma on uptake, but a joint hypothesis as
written in the above.
B.3 Causal impacts of fear
It is suggested that receiving results also becomes an impediment to know one’s status. In a
study measuring returns for STD test results to 258 at-risk adolescents who have voluntarily come
to the clinic in Cleveland, US between 1997 and 1998, 58% choose not to return to be notified the
results (Lazebnik et al., 2001). The returners are more likely to have had private health insurance,
unprotected sex while using illegal drugs and alcohol, and previous attendance at the clinic only for
HIV testing. This behaviour is consistent with hyperbolic discounting of Ainslie and Haslam (1992);
Laibson (1997), or resultant procrastination.
C Standard errors of marginal effects in probit estimation
Probit marginal eect:
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Given that we do not know which xi to use, one can average over all observations. That is:
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In a vector form, the vector function is given as:
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Its gradient is not symmetric (as functional forms di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So asymptotic covariance of a() is DV[]D0.
For a linear combination of parameters, say,  j + k = g0 with g j = gk = 1 and other elements
are zero, we have:
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The asymptotic variance of this linear combination of parameters is given by taking a derivative for
all parameters. Its typical element m , j and m , k is given by:
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Its gradient is given as
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Then its asymptotic covariance matrix is given by DGV[]D0G.
When evaluating the dierential impacts of arms by ethnicity, we need to compare if ethnicity
impacts may dier under each arm. So for Africans, for example, average impact of opt out is given
by africans  opt out + africans.
D Descriptive statistics
In controlling for the riskiness of each respondents, we asked a series of queries about past risky
behaviours. In addition, we asked how they evaluate their risk of infection. We asked:
What do you think the chances are that you are infected with HIV? Please choose one from scale of 0 to 10
and circle the chosen number. “0” means “no likelihood” and “10” means “certain”.
Use of subjective probability from survey questions is discussed and encouraged generally in
Manski (2004), and in Delavande et al. (2011) under a developing country contect. Subjective prob-
abilities, rather than Lickert scales oft used in other literature, has an advantage of being comparable
intra- and inter-personally, thereby allowing to be used directly in estimation. Disadvantage is the
possibility of misunderstanding of probability concept by the respondents. However, as we have
explained the meaning of scales to all subjects, we believe such a possibility is minimal.
E Detailed Estimated Results and Robustness Checks
In Table A3, Table A4, Table A5Table A6, we show the estimated results of probit model under sam-
ple selection criterion up to (3). As can be seen in uptake among MSP, the point estimates are more
than halved in magnitude and standard errors increased slightly, resulting in less precise estimates
but still retain statistical significance at 5% level. Results for HCT sample remain unchanged from
Table 6, as there was fewer observations dropped between criteria (2) and criteria (3).
Table 5, Table 6, Table A7, Table A8, Table 7, Table 8 show estimated results of uptake MSP, uptake
HCT, infection MSP, infection HCT, detection MSP, detection HCT, respectively. Infection probits
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Table A1: Variable Description
.
.
.
short questions
uptake HIV test
infection Rapid test result
age / 10 Age / 10
(age / 10)2 (Age / 10) squared
BMI / 10 BMI / 10
number of bf gf Extramarital parters, BF, GF: How many people did you have sex with?
visitor number of the area Visitor number
multiple partners indicator if there is more than 1 sex partner
casual partners indicator if there is a sex partner other than spouse, boyfriend, girlfriend
single indicator if number of spousal sex parnter is zero
STD times Howmany times in the past 10 years have you had a sexually transmitted infection such as gonorrhoea,
syphilis, genital herpes, genital warts, genital ulcers, clamidia?
STI screen Number of armatives to STI screening questions
TB screen Number of armatives to TB screening questions
subjective probability What do you think the chances are that you are infected with HIV? Part 1
days since HCT began / 100 Days / 100 since the start of HCTI
(days since HCT began / 100)2 days squared
hourly paid workers What is your grade level? Hourly (yes) / Salaried (no)?
years at Company Years worked
HCT before Have you ever taken an HIV counseling and testing before?
gender (female = 1) Sex
correct on life year question indicator if correct to “life years of PLWHA” question
relatives positive Relatives: Are HIV positive?
friends positive Friends/Neighbours: Are HIV positive?
colleagues positive Colleagues: Are HIV positive?
relatives died Relatives: Have died of HIV/AIDS?
friends died Friends/Neighbours: Have died of HIV/AIDS?
colleagues died Colleagues: Have died of HIV/AIDS?
use only HIV test taker sample and the regressand takes the value of 1 if found to be HIV positive,
0 otherwise. Detection probit estimates the incidence of detecting HIV positive cases, where the
regressand takes the value of 1 if tested and infected, 0 otherwise. Detection probit may be of
interest to policy makers who wants to know at what rate one can find HIV positive cases under
certain interventions.
Infection probit estimates show Africans and Colored are more likely to be infected than Indians,
Whites and Others are less likely to be infected than Indians. Tertiary education is strongly negatively
associated with infection probability. Estimates on elapsed period since the launch of the promotion
is positive, indicating that, as the days pass, more number of riskier individuals have taken the tests.
We note positive estimates on risk assessment and negative estimates on supportive information
which suggest that we have picked up, riskier Indians under the former and less risker Indians under
the latter. Nevertheless, risk assessment picked up less risky individuals among Africans and Col-
ored, and Whites and Others. So it is not particularly eective for the risky population. The arm of
supportive information picked up even further less risky Africans and Colored, so it is also not ef-
fective in attracting the risky group. As suggested in the exploratory analysis, subjective probability
is positively correlated with the infection probability.
In Figure A1, we plot the uptake rates by nurse and ethnicity of subjects. All nurses are African
females. We observe small variations in uptake rates among Indians and White-Others by nurse, but
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Table A2: Descriptive Statistics
.
.
.
variables min 25% median 75% max mean std 0s NAs n
uptake 0:000 1:000 1:000 1:000 1:000 0:800 0:400 469 0 2722
infection 0:000 0:000 0:000 0:000 1:000 0:000 0:200 2155 471 2722
african / colored 0:000 0:000 1:000 1:000 1:000 0:700 0:500 940 0 2722
indian 0:000 0:000 0:000 0:000 1:000 0:200 0:400 2057 0 2722
white / other 0:000 0:000 0:000 0:000 1:000 0:100 0:300 2447 0 2722
hct 0:000 0:000 0:000 1:000 1:000 0:500 0:500 1404 0 2722
msp 0:000 0:000 1:000 1:000 1:000 0:500 0:500 1318 0 2722
high school 0:000 0:000 0:000 1:000 1:000 0:400 0:500 1682 11 2722
higher primary 0:000 0:000 0:000 1:000 1:000 0:400 0:500 1509 11 2722
lower primary or less 0:000 0:000 0:000 0:000 1:000 0:100 0:300 2390 11 2722
master’s degree 0:000 0:000 0:000 0:000 1:000 0:000 0:100 2694 11 2722
tertiary education 0:000 0:000 0:000 0:000 1:000 0:100 0:200 2569 11 2722
age / 10 0:100 2:900 3:600 4:600 6:500 3:800 1:000 0 5 2722
(age / 10)2 0:000 8:400 13:000 21:200 42:200 15:300 8:200 0 5 2722
(BMI-22) / 10  1:300 0:200 0:500 0:800 8:900 0:500 0:600 0 3 2722
number of bf gf 0:000 0:000 0:000 1:000 12:000 0:600 0:900 1537 13 2722
visitor number of the area 1:000 1:000 3:000 4:000 21:000 3:500 2:900 0 0 2722
multiple partners 0:000 0:000 0:000 0:000 1:000 0:200 0:400 2064 0 2722
casual partners 0:000 0:000 0:000 0:000 1:000 0:100 0:200 2544 0 2722
single 0:000 0:000 0:000 1:000 1:000 0:400 0:500 1621 0 2722
STD times 0:000 0:000 0:000 0:000 20:000 0:300 1:000 2319 6 2722
STI screen 0:000 2:000 2:000 2:000 10:000 2:000 0:800 183 4 2722
TB screen 0:000 0:000 0:000 0:000 10:000 0:600 1:300 2105 4 2722
subjective probability (0 - 1) 0:000 0:000 0:000 0:300 1:000 0:200 0:200 1297 146 2722
days since HCT began / 100 0:600 0:800 1:300 1:500 1:800 1:200 0:400 0 0 2722
(days since HCT began / 100)2 0:300 0:700 1:600 2:300 3:100 1:500 0:900 0 0 2722
hourly paid workers 0:000 0:000 1:000 1:000 1:000 0:500 0:500 1231 32 2722
years at Company 0:000 4:000 7:000 19:000 40:000 11:100 9:500 1 9 2722
have tested before 0:000 0:000 1:000 1:000 1:000 0:700 0:400 697 0 2722
gender (female = 1) 0:000 0:000 0:000 0:000 1:000 0:200 0:400 2175 9 2722
correct on life year question 0:000 0:000 1:000 1:000 1:000 0:700 0:500 828 0 2722
relatives positive 0:000 0:000 0:000 1:000 1:000 0:300 0:400 2012 23 2722
friends positive 0:000 0:000 0:000 0:000 1:000 0:200 0:400 2087 22 2722
colleagues positive 0:000 0:000 0:000 0:000 1:000 0:100 0:300 2418 22 2722
relatives died 0:000 0:000 0:000 1:000 1:000 0:300 0:400 1984 34 2722
friends died 0:000 0:000 0:000 0:000 1:000 0:200 0:400 2117 38 2722
colleagues died 0:000 0:000 0:000 0:000 1:000 0:100 0:300 2378 30 2722
Notes: 1. Based on the sample using delayed notification as the control. Following observations are dropped: indi-
viduals with route, ethnicity, test taking information is missing, individuals who are not tested but answers
“know about my status”, tested positive in prevalence study, and own subjective probability of infection is
1.
variations are considerable among the Africans. This implies that nurse’s individual contribution can
be large, and we may need to take it into considerations when selecting and training the nurses.
In Table A9 and Table A10, we show the estimated uptake probit results using the nurse fixed
eects in place of area fixed eects. We cannot use the both fixed eects simultaneously in the same
regression as they are highly collinear and standard errors of nurse eects become very large. The
estimated results do not dier from our main results and show their robustness.
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Table A3: Uptake Probit, MSP Sample, Marginal Effects, Criteria (3)
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:176 1:158 1:327 1:332 1:296 1:430 1:304 1:333 1:311
(0:026) (0:183) (0:205) (0:212) (0:213) (0:233) (0:233) (0:314) (0:310)
arm (optout) 0:015 0:014 0:013 0:011 0:033 0:031 0:027 0:026 0:028
(0:033) (0:031) (0:030) (0:031) (0:044) (0:045) (0:043) (0:044) (0:044)
arm (assess) 0:068 0:057 0:057 0:056 0:068 0:067 0:060 0:049 0:050
(0:037) (0:035) (0:034) (0:034) (0:039) (0:040) (0:039) (0:039) (0:040)
arm (supp) 0:067 0:064 0:060 0:058 0:159 0:156 0:141 0:142 0:143
(0:033) (0:031) (0:031) (0:031) (0:042) (0:042) (0:040) (0:042) (0:042)
african / colored  0:397  0:379  0:375  0:378  0:364  0:312  0:297  0:302
(0:053) (0:053) (0:054) (0:056) (0:055) (0:054) (0:054) (0:054)
white / other  0:075  0:083  0:089 0:117 0:120 0:115 0:115 0:107
(0:084) (0:095) (0:094) (0:081) (0:081) (0:077) (0:080) (0:079)
age / 10  0:328  0:360  0:353  0:350  0:386  0:326  0:343  0:346
(0:090) (0:095) (0:096) (0:096) (0:106) (0:107) (0:105) (0:103)
(age / 10)2 0:041 0:045 0:045 0:045 0:048 0:041 0:041 0:041
(0:011) (0:011) (0:012) (0:012) (0:013) (0:013) (0:013) (0:012)
BMI / 10  0:038  0:032  0:033  0:034  0:036  0:041  0:042  0:042
(0:020) (0:018) (0:018) (0:018) (0:018) (0:018) (0:018) (0:018)
number of bf gf  0:028  0:028  0:028  0:028  0:009  0:004  0:008  0:009
(0:013) (0:013) (0:013) (0:013) (0:019) (0:019) (0:018) (0:019)
higher primary 0:002 0:003 0:001  0:019  0:018  0:022
(0:033) (0:034) (0:034) (0:035) (0:036) (0:036)
high school 0:017 0:019 0:015  0:003  0:028  0:038
(0:038) (0:038) (0:038) (0:039) (0:041) (0:041)
tertiary education 0:016 0:023 0:008  0:008  0:084  0:064
(0:208) (0:203) (0:210) (0:207) (0:221) (0:236)
arm (optout) * african / coloured  0:057  0:053  0:059  0:039  0:044
(0:151) (0:151) (0:145) (0:148) (0:148)
arm (optout) * white / other 0:093 0:109 0:088 0:125 0:110
(0:245) (0:245) (0:231) (0:235) (0:234)
arm (assess) * african / coloured 0:067 0:063 0:056 0:061 0:072
(0:135) (0:134) (0:130) (0:131) (0:133)
arm (assess) * white / other 0:373 0:376 0:359 0:359 0:331
(0:191) (0:190) (0:182) (0:186) (0:186)
arm (supp) * african / coloured  0:023  0:020  0:026  0:030  0:039
(0:147) (0:147) (0:142) (0:143) (0:142)
arm (supp) * white / other 1:034 1:017 0:972 0:961 0:932
(0:194) (0:192) (0:184) (0:188) (0:186)
multiple partners  0:022  0:016  0:019  0:013
(0:036) (0:037) (0:036) (0:036)
other partners 0:056 0:038 0:032 0:027
(0:046) (0:045) (0:044) (0:045)
single  0:059  0:051  0:044  0:045
(0:034) (0:034) (0:034) (0:034)
STD times  0:005  0:007  0:006  0:005
(0:012) (0:014) (0:014) (0:014)
STI screen  0:014  0:007  0:006  0:005
(0:014) (0:015) (0:015) (0:015)
TB screen  0:009  0:006  0:005  0:006
(0:008) (0:008) (0:008) (0:008)
subjective probability  0:119  0:116  0:108
(0:052) (0:051) (0:052)
days since HCT began / 100 0:169 0:128
(0:354) (0:354)
(days since HCT began / 100)2  0:112  0:093
(0:150) (0:151)
hourly paid workers  0:046  0:038
(0:032) (0:032)
years at Company 0:001 0:001
(0:002) (0:002)
HCT before 0:068
(0:026)
area no no yes yes yes yes yes yes yes
pseudo R2 0:004 0:107 0:127 0:128 0:13 0:134 0:134 0:142 0:147
n 1361 1353 1353 1348 1348 1345 1262 1242 1242
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP sample only. xcluded observations under an additional criteria (3) who rejects testing by saying
that one is sure about status and claims that subjective probability of infection is 100% (59 observa-
tions).
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Table A4: Uptake Probit, HCT Sample, Marginal Effects, Criteria (3)
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:187 0:502 0:484 0:482 0:498 0:556 0:540 0:607 0:607
(0:022) (0:131) (0:135) (0:130) (0:136) (0:144) (0:144) (0:231) (0:232)
arm (optout) 0:001 0:005 0:005 0:004 0:016 0:017 0:017 0:019 0:019
(0:022) (0:021) (0:019) (0:019) (0:020) (0:020) (0:020) (0:021) (0:021)
arm (assess)  0:016  0:010 0:006 0:005 0:003 0:003 0:003 0:008 0:008
(0:018) (0:018) (0:018) (0:019) (0:018) (0:018) (0:018) (0:018) (0:018)
arm (supp)  0:013  0:009  0:012  0:012  0:009  0:010  0:014  0:010  0:010
(0:020) (0:020) (0:022) (0:021) (0:019) (0:019) (0:018) (0:019) (0:019)
african / colored  0:065  0:094  0:095  0:098  0:092  0:072  0:070  0:070
(0:019) (0:019) (0:018) (0:020) (0:019) (0:018) (0:018) (0:018)
white / other  0:050  0:045  0:040  0:019  0:016  0:015  0:011  0:011
(0:024) (0:022) (0:022) (0:023) (0:023) (0:021) (0:021) (0:021)
age / 10  0:147  0:135  0:129  0:139  0:160  0:162  0:157  0:157
(0:066) (0:070) (0:070) (0:074) (0:078) (0:078) (0:081) (0:081)
(age / 10)2 0:018 0:017 0:016 0:017 0:019 0:019 0:017 0:017
(0:009) (0:009) (0:009) (0:010) (0:010) (0:010) (0:010) (0:011)
BMI / 10  0:010  0:008  0:008  0:007  0:004 0:001 0:002 0:002
(0:012) (0:012) (0:012) (0:012) (0:011) (0:011) (0:012) (0:012)
number of bf gf 0:003  0:002  0:001  0:001 0:001 0:005 0:002 0:002
(0:005) (0:005) (0:005) (0:005) (0:007) (0:007) (0:006) (0:006)
higher primary  0:025  0:022  0:020  0:019  0:021  0:021
(0:034) (0:033) (0:032) (0:031) (0:033) (0:033)
high school 0:007 0:009 0:008 0:007 0:005 0:005
(0:035) (0:034) (0:032) (0:031) (0:035) (0:035)
tertiary education 0:003 0:011 0:012 0:009 0:008 0:008
(0:040) (0:040) (0:037) (0:035) (0:039) (0:039)
master’s degree  0:067  0:058  0:066  0:070  0:071  0:071
(0:052) (0:050) (0:049) (0:047) (0:050) (0:050)
arm (optout) * african / coloured 0:004 0:016 0:010 0:007 0:007
(0:053) (0:052) (0:047) (0:048) (0:048)
arm (optout) * white / other  0:132  0:120  0:114  0:109  0:109
(0:058) (0:057) (0:052) (0:054) (0:054)
arm (assess) * african / coloured 0:012 0:014  0:027  0:022  0:022
(0:046) (0:045) (0:041) (0:043) (0:043)
arm (assess) * white / other  0:049  0:048  0:077  0:075  0:075
(0:061) (0:061) (0:054) (0:054) (0:054)
arm (supp) * african / coloured  0:020  0:014  0:021  0:011  0:011
(0:045) (0:044) (0:042) (0:043) (0:043)
arm (supp) * white / other  0:001  0:002  0:004 0:000 0:001
(0:059) (0:059) (0:055) (0:056) (0:056)
multiple partners 0:032 0:027 0:031 0:031
(0:022) (0:026) (0:025) (0:025)
other partners  0:014  0:009  0:014  0:014
(0:028) (0:028) (0:028) (0:028)
single  0:034  0:027  0:022  0:022
(0:015) (0:016) (0:016) (0:016)
STD times  0:009  0:006  0:005  0:005
(0:005) (0:005) (0:004) (0:004)
STI screen  0:001  0:000  0:002  0:002
(0:007) (0:007) (0:007) (0:007)
TB screen  0:003  0:003  0:002  0:002
(0:006) (0:006) (0:006) (0:006)
subjective probability  0:121  0:121  0:120
(0:027) (0:026) (0:026)
days since HCT began / 100  0:256  0:255
(0:321) (0:319)
(days since HCT began / 100)2 0:131 0:130
(0:138) (0:137)
hourly paid workers 0:001 0:001
(0:021) (0:021)
years at Company 0:002 0:002
(0:001) (0:001)
HCT before  0:001
(0:016)
area no no yes yes yes yes yes yes yes
pseudo R2 0:002 0:051 0:155 0:168 0:187 0:205 0:26 0:265 0:265
n 1310 1307 1307 1302 1302 1300 1240 1225 1225
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT sample only. Excluded observations under an additional criteria (3) who rejects testing by saying
that one is sure about status and claims that subjective probability of infection is 100% (59 observa-
tions).
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Table A5: Detection Probit, MSP Sample, Marginal Effects, Criteria (3)
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:151  0:367  0:374  0:376  0:607  0:576  0:860  0:994  0:996
(0:010) (0:111) (0:114) (0:117) (0:126) (0:134) (0:150) (0:189) (0:192)
arm (optout) 0:003 0:006 0:008 0:008 0:007 0:009 0:010 0:006 0:007
(0:015) (0:014) (0:014) (0:014) (0:010) (0:010) (0:012) (0:012) (0:012)
arm (assess) 0:009 0:012 0:011 0:011 0:082 0:083 0:084 0:085 0:085
(0:016) (0:015) (0:015) (0:015) (0:015) (0:015) (0:016) (0:017) (0:017)
arm (supp)  0:030  0:028  0:028  0:028  0:021  0:019  0:014  0:027  0:026
(0:017) (0:017) (0:017) (0:017) (0:012) (0:012) (0:013) (0:015) (0:015)
african / colored 0:085 0:085 0:085 0:302 0:301 0:274 0:281 0:283
(0:031) (0:031) (0:030) (0:027) (0:027) (0:027) (0:028) (0:029)
white / other  0:254  0:264  0:280  0:072  0:068  0:066  0:066  0:070
(0:036) (0:037) (0:039) (0:013) (0:014) (0:015) (0:015) (0:017)
age / 10 0:069 0:062 0:060 0:061 0:040 0:019 0:014 0:012
(0:056) (0:056) (0:058) (0:058) (0:063) (0:065) (0:067) (0:068)
(age / 10)2  0:008  0:007  0:007  0:007  0:005  0:002  0:002  0:002
(0:007) (0:007) (0:007) (0:007) (0:008) (0:008) (0:008) (0:008)
BMI / 10  0:002  0:002  0:003  0:002  0:002  0:006  0:007  0:007
(0:010) (0:010) (0:010) (0:010) (0:010) (0:010) (0:010) (0:010)
number of bf gf 0:010 0:009 0:009 0:009 0:012 0:015 0:014 0:014
(0:005) (0:005) (0:005) (0:005) (0:008) (0:008) (0:008) (0:008)
higher primary 0:005 0:004 0:006  0:003  0:002  0:003
(0:018) (0:018) (0:018) (0:019) (0:020) (0:021)
high school 0:004 0:003 0:005  0:007  0:008  0:006
(0:020) (0:020) (0:020) (0:021) (0:023) (0:023)
tertiary education  0:336  0:352  0:354  0:328  0:350  0:347
(0:043) (0:043) (0:043) (0:044) (0:046) (0:046)
arm (optout) * african / coloured 0:002 0:002 0:004 0:011 0:010
(0:016) (0:017) (0:018) (0:021) (0:023)
arm (optout) * white / other  0:002  0:002 0:018 0:012 0:020
(0:017) (0:020) (0:027) (0:032) (0:035)
arm (assess) * african / coloured  0:324  0:325  0:299  0:302  0:305
(0:046) (0:047) (0:047) (0:049) (0:049)
arm (assess) * white / other  0:332  0:329  0:290  0:302  0:296
(0:048) (0:049) (0:045) (0:051) (0:053)
arm (supp) * african / coloured  0:022  0:025  0:022  0:024  0:028
(0:019) (0:020) (0:020) (0:021) (0:021)
arm (supp) * white / other 0:003 0:005 0:020 0:012 0:014
(0:021) (0:024) (0:023) (0:030) (0:031)
multiple partners  0:008  0:029  0:030  0:032
(0:018) (0:019) (0:020) (0:020)
other partners 0:002 0:009 0:012 0:012
(0:020) (0:021) (0:021) (0:020)
single  0:017  0:022  0:019  0:018
(0:018) (0:019) (0:019) (0:019)
STD times 0:004  0:002  0:002  0:003
(0:004) (0:004) (0:004) (0:004)
STI screen 0:007 0:004 0:004 0:004
(0:005) (0:005) (0:006) (0:006)
TB screen 0:001 0:002 0:002 0:002
(0:003) (0:004) (0:004) (0:004)
subjective probability 0:095 0:097 0:098
(0:024) (0:024) (0:024)
days since HCT began / 100 0:279 0:299
(0:163) (0:161)
(days since HCT began / 100)2  0:116  0:125
(0:069) (0:069)
hourly paid workers  0:010  0:012
(0:012) (0:013)
years at Company 0:001 0:001
(0:001) (0:001)
HCT before  0:019
(0:013)
area no no yes yes yes yes yes yes yes
pseudo R2 0:014 0:076 0:102 0:102 0:107 0:116 0:169 0:179 0:185
n 1361 1353 1353 1348 1348 1345 1262 1242 1242
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP sample only. Excluded observations under an additional criteria (3) who rejects testing by saying
that one is sure about status and claims that subjective probability of infection is 100% (59 observa-
tions).
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Table A6: Detection Probit, HCT Sample, Marginal Effects, Criteria (3)
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:117  0:518  0:475  0:460  0:456  0:473  0:352  0:453  0:460
(0:008) (0:083) (0:093) (0:095) (0:095) (0:102) (0:093) (0:153) (0:159)
arm (optout)  0:005  0:003 0:001 0:004  0:001  0:003  0:001  0:002  0:001
(0:014) (0:012) (0:012) (0:012) (0:010) (0:009) (0:008) (0:009) (0:011)
arm (assess)  0:023  0:025  0:021  0:019  0:017  0:016  0:013  0:016  0:016
(0:015) (0:014) (0:014) (0:014) (0:013) (0:012) (0:011) (0:012) (0:011)
arm (supp)  0:009  0:011  0:006  0:006  0:004  0:006  0:005  0:014  0:015
(0:012) (0:012) (0:011) (0:011) (0:008) (0:009) (0:009) (0:012) (0:013)
african / colored 0:258 0:248 0:249 0:245 0:228 0:177 0:182 0:179
(0:026) (0:026) (0:029) (0:027) (0:026) (0:023) (0:024) (0:027)
white / other  0:002  0:008  0:006  0:001  0:014  0:014  0:007  0:002
(0:002) (0:029) (0:009) (0:006) (0:012) (0:014) (0:014) (0:013)
age / 10 0:085 0:077 0:069 0:069 0:076 0:031 0:019 0:026
(0:037) (0:042) (0:043) (0:043) (0:048) (0:045) (0:045) (0:044)
(age / 10)2  0:009  0:009  0:008  0:008  0:008  0:002  0:001  0:001
(0:005) (0:005) (0:005) (0:005) (0:006) (0:006) (0:006) (0:006)
BMI / 10  0:001  0:004  0:004  0:004  0:006  0:002  0:001  0:002
(0:011) (0:011) (0:011) (0:011) (0:010) (0:010) (0:011) (0:011)
number of bf gf 0:004 0:003 0:002 0:002  0:003  0:007  0:006  0:006
(0:003) (0:003) (0:003) (0:003) (0:005) (0:005) (0:006) (0:007)
higher primary 0:011 0:011 0:013 0:006 0:009 0:013
(0:017) (0:017) (0:017) (0:018) (0:020) (0:018)
high school  0:014  0:014  0:011  0:020  0:014  0:009
(0:020) (0:020) (0:020) (0:020) (0:023) (0:021)
tertiary education  0:218  0:218  0:200  0:172  0:181  0:181
(0:028) (0:028) (0:027) (0:037) (0:039) (0:040)
master’s degree 0:003 0:004 0:010 0:022 0:027 0:035
(0:024) (0:024) (0:025) (0:022) (0:026) (0:025)
arm (optout) * african / coloured 0:012 0:005 0:005 0:008 0:005
(0:021) (0:020) (0:014) (0:020) (0:029)
arm (optout) * white / other  0:010  0:008  0:019  0:023  0:006
(0:016) (0:023) (0:020) (0:026) (0:041)
arm (assess) * african / coloured  0:011  0:012 0:003 0:011 0:003
(0:023) (0:022) (0:018) (0:023) (0:028)
arm (assess) * white / other  0:020 0:004 0:012 0:015  0:000
(0:018) (0:026) (0:022) (0:024) (0:042)
arm (supp) * african / coloured  0:006  0:008 0:007 0:012 0:008
(0:015) (0:014) (0:012) (0:020) (0:031)
arm (supp) * white / other  0:001 0:019  0:005  0:001 0:009
(0:018) (0:027) (0:033) (0:032) (0:037)
multiple partners 0:002 0:003 0:002 0:000
(0:012) (0:012) (0:012) (0:013)
other partners  0:054  0:047  0:048  0:055
(0:021) (0:018) (0:018) (0:021)
single 0:027 0:018 0:017 0:013
(0:011) (0:011) (0:011) (0:011)
STD times 0:009 0:004 0:004 0:003
(0:004) (0:003) (0:003) (0:004)
STI screen 0:002 0:004 0:004 0:004
(0:004) (0:003) (0:003) (0:003)
TB screen  0:000  0:002  0:003  0:002
(0:003) (0:003) (0:003) (0:003)
subjective probability 0:073 0:074 0:076
(0:019) (0:019) (0:019)
days since HCT began / 100 0:190 0:221
(0:166) (0:172)
(days since HCT began / 100)2  0:080  0:091
(0:068) (0:070)
hourly paid workers 0:020 0:020
(0:014) (0:014)
years at Company  0:000  0:001
(0:001) (0:001)
HCT before  0:028
(0:011)
area no no yes yes yes yes yes yes yes
pseudo R2 0:009 0:194 0:244 0:261 0:261 0:3 0:371 0:381 0:408
n 1310 1307 1307 1302 1302 1300 1240 1225 1225
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT sample only. Excluded observations under an additional criteria (3) who rejects testing by saying
that one is sure about status and claims that subjective probability of infection is 100% (59 observa-
tions).
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Table A7: Infection Probit, MSP Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:171  0:504  0:531  0:540  0:825  0:791  1:101  1:296  1:289
(0:013) (0:149) (0:156) (0:160) (0:176) (0:183) (0:200) (0:259) (0:261)
arm (optout) 0:003 0:007 0:009 0:009 0:010 0:013 0:013 0:010 0:010
(0:020) (0:019) (0:018) (0:018) (0:013) (0:014) (0:014) (0:015) (0:015)
arm (assess) 0:006 0:009 0:009 0:009 0:098 0:098 0:093 0:096 0:095
(0:021) (0:020) (0:019) (0:020) (0:020) (0:020) (0:020) (0:022) (0:023)
arm (supp)  0:045  0:042  0:042  0:042  0:027  0:027  0:019  0:036  0:035
(0:022) (0:022) (0:022) (0:022) (0:016) (0:016) (0:017) (0:019) (0:019)
african / colored 0:122 0:119 0:120 0:384 0:380 0:328 0:338 0:340
(0:038) (0:039) (0:038) (0:035) (0:037) (0:033) (0:036) (0:038)
white / other  0:312  0:323  0:342  0:087  0:081  0:076  0:078  0:083
(0:046) (0:047) (0:048) (0:016) (0:020) (0:020) (0:020) (0:024)
age / 10 0:116 0:110 0:109 0:110 0:081 0:046 0:046 0:042
(0:075) (0:075) (0:078) (0:079) (0:084) (0:083) (0:086) (0:087)
(age / 10)2  0:014  0:013  0:013  0:013  0:010  0:005  0:006  0:005
(0:009) (0:009) (0:010) (0:010) (0:010) (0:010) (0:010) (0:010)
BMI / 10  0:001  0:001  0:002  0:001  0:001  0:005  0:006  0:006
(0:012) (0:012) (0:012) (0:012) (0:013) (0:012) (0:012) (0:012)
number of bf gf 0:017 0:016 0:016 0:016 0:017 0:021 0:020 0:021
(0:006) (0:006) (0:006) (0:006) (0:009) (0:009) (0:009) (0:008)
higher primary 0:008 0:007 0:011  0:001 0:001  0:001
(0:023) (0:024) (0:024) (0:024) (0:026) (0:027)
high school 0:008 0:006 0:009  0:005  0:002 0:001
(0:026) (0:026) (0:026) (0:026) (0:028) (0:029)
tertiary education  0:330  0:348  0:327  0:347  0:359  0:383
(0:068) (0:068) (0:067) (0:071) (0:072) (0:074)
arm (optout) * african / coloured  0:003  0:002 0:003 0:009 0:005
(0:028) (0:027) (0:027) (0:033) (0:034)
arm (optout) * white / other 0:005 0:000 0:040 0:047 0:055
(0:029) (0:028) (0:039) (0:054) (0:057)
arm (assess) * african / coloured  0:406  0:406  0:360  0:372  0:375
(0:061) (0:061) (0:062) (0:066) (0:065)
arm (assess) * white / other  0:400  0:396  0:318  0:325  0:316
(0:062) (0:062) (0:056) (0:068) (0:068)
arm (supp) * african / coloured  0:042  0:046  0:047  0:054  0:060
(0:029) (0:030) (0:029) (0:032) (0:032)
arm (supp) * white / other 0:009 0:007 0:031 0:031 0:035
(0:027) (0:032) (0:035) (0:045) (0:047)
multiple partners  0:005  0:034  0:033  0:035
(0:022) (0:023) (0:023) (0:023)
other partners  0:006 0:004 0:008 0:007
(0:027) (0:027) (0:027) (0:026)
single  0:016  0:023  0:020  0:019
(0:024) (0:024) (0:024) (0:023)
STD times 0:004  0:003  0:004  0:005
(0:005) (0:004) (0:004) (0:004)
STI screen 0:013 0:006 0:006 0:005
(0:007) (0:008) (0:008) (0:009)
TB screen 0:003 0:005 0:004 0:004
(0:004) (0:004) (0:004) (0:004)
subjective probability 0:139 0:142 0:140
(0:031) (0:032) (0:033)
days since HCT began / 100 0:345 0:367
(0:212) (0:207)
(days since HCT began / 100)2  0:137  0:148
(0:091) (0:089)
hourly paid workers  0:005  0:008
(0:016) (0:016)
years at Company 0:001 0:001
(0:001) (0:001)
HCT before  0:028
(0:017)
area no no yes yes yes yes yes yes yes
pseudo R2 0:016 0:115 0:135 0:136 0:142 0:153 0:22 0:233 0:241
n 1017 1014 1014 1010 1010 1008 976 961 961
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP taker sample only. Sample dropped plausibly knowing HIV infected individuals who are not
tested but answers “know about my status”, tested positive in prevalence study, and own subjective
probability of infection is 1.
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Table A8: Infection Probit, HCT Sample, Marginal Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept)  0:121  0:555  0:512  0:498  0:494  0:512  0:373  0:455  0:448
(0:008) (0:088) (0:098) (0:100) (0:099) (0:106) (0:097) (0:167) (0:170)
arm (optout)  0:005  0:005 0:001 0:003  0:002  0:004  0:002  0:003  0:001
(0:014) (0:013) (0:013) (0:013) (0:010) (0:009) (0:009) (0:012) (0:012)
arm (assess)  0:024  0:026  0:023  0:020  0:020  0:020  0:012  0:014  0:013
(0:016) (0:015) (0:015) (0:015) (0:014) (0:013) (0:011) (0:012) (0:011)
arm (supp)  0:009  0:010  0:005  0:005  0:003  0:004 0:000  0:007  0:007
(0:013) (0:012) (0:012) (0:012) (0:010) (0:009) (0:010) (0:013) (0:013)
african / colored 0:272 0:263 0:263 0:260 0:240 0:180 0:180 0:177
(0:028) (0:028) (0:032) (0:029) (0:027) (0:026) (0:027) (0:029)
white / other  0:002  0:006 0:001 0:001  0:013  0:012  0:004 0:001
(0:002) (0:028) (0:011) (0:007) (0:012) (0:013) (0:013) (0:012)
age / 10 0:098 0:090 0:084 0:084 0:094 0:048 0:037 0:041
(0:039) (0:044) (0:044) (0:044) (0:048) (0:044) (0:045) (0:045)
(age / 10)2  0:011  0:010  0:010  0:010  0:010  0:005  0:003  0:003
(0:005) (0:006) (0:006) (0:006) (0:006) (0:006) (0:006) (0:006)
BMI / 10  0:001  0:004  0:004  0:004  0:008  0:006  0:005  0:006
(0:012) (0:012) (0:012) (0:012) (0:010) (0:010) (0:011) (0:011)
number of bf gf 0:004 0:002 0:002 0:002  0:004  0:009  0:008  0:007
(0:003) (0:003) (0:003) (0:003) (0:005) (0:006) (0:007) (0:007)
higher primary 0:009 0:009 0:009  0:001 0:002 0:006
(0:018) (0:019) (0:018) (0:016) (0:018) (0:016)
high school  0:016  0:016  0:015  0:027  0:022  0:017
(0:021) (0:021) (0:021) (0:019) (0:021) (0:019)
tertiary education  0:234  0:234  0:214  0:186  0:187  0:185
(0:030) (0:030) (0:029) (0:039) (0:040) (0:041)
master’s degree  0:005  0:005 0:049 0:026 0:024 0:023
(0:030) (0:030) (0:041) (0:038) (0:039) (0:037)
arm (optout) * african / coloured 0:014 0:006 0:003 0:011 0:001
(0:026) (0:025) (0:016) (0:027) (0:034)
arm (optout) * white / other 0:002 0:000  0:026  0:018  0:017
(0:028) (0:030) (0:035) (0:048) (0:056)
arm (assess) * african / coloured  0:007  0:003 0:014 0:023 0:011
(0:027) (0:027) (0:021) (0:027) (0:030)
arm (assess) * white / other  0:019 0:013 0:017 0:028 0:007
(0:017) (0:027) (0:022) (0:023) (0:043)
arm (supp) * african / coloured  0:007  0:007 0:012 0:017 0:008
(0:017) (0:016) (0:013) (0:021) (0:029)
arm (supp) * white / other 0:000 0:026  0:003 0:009 0:004
(0:016) (0:026) (0:036) (0:036) (0:027)
multiple partners 0:000  0:001  0:002  0:004
(0:013) (0:012) (0:012) (0:013)
other partners  0:056  0:053  0:054  0:058
(0:024) (0:020) (0:020) (0:023)
single 0:030 0:020 0:017 0:012
(0:012) (0:012) (0:012) (0:012)
STD times 0:010 0:006 0:005 0:005
(0:004) (0:003) (0:003) (0:004)
STI screen 0:001 0:003 0:003 0:003
(0:004) (0:004) (0:004) (0:004)
TB screen 0:000  0:002  0:003  0:002
(0:003) (0:003) (0:003) (0:003)
subjective probability 0:095 0:096 0:093
(0:025) (0:025) (0:025)
days since HCT began / 100 0:175 0:187
(0:170) (0:173)
(days since HCT began / 100)2  0:076  0:080
(0:070) (0:071)
hourly paid workers 0:020 0:021
(0:015) (0:014)
years at Company  0:001  0:001
(0:001) (0:001)
HCT before  0:025
(0:012)
area no no yes yes yes yes yes yes yes
pseudo R2 0:008 0:203 0:254 0:271 0:271 0:316 0:414 0:425 0:445
n 1234 1231 1231 1226 1226 1224 1170 1156 1156
Notes 1. Cluster robust standard errors in parenthesis. Clusters are area  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT taker sample only. Sample dropped plausibly knowing HIV infected individuals who are not
tested but answers “know about my status”, tested positive in prevalence study, and own subjective
probability of infection is 1.
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Table A9: Uptake Probit, MSP Sample, Marginal Effects, Nurse Fixed Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:167 1:286 1:447 1:418 1:383 1:491 1:268 1:299 1:287
(0:027) (0:186) (0:252) (0:261) (0:261) (0:269) (0:256) (0:330) (0:324)
arm (optout) 0:007 0:006 0:004 0:004 0:027 0:027 0:028 0:026 0:027
(0:034) (0:032) (0:031) (0:032) (0:043) (0:044) (0:041) (0:042) (0:042)
arm (assess) 0:061 0:049 0:044 0:043 0:045 0:045 0:042 0:029 0:031
(0:036) (0:034) (0:034) (0:034) (0:038) (0:039) (0:037) (0:038) (0:038)
arm (supp) 0:063 0:068 0:059 0:057 0:172 0:171 0:154 0:149 0:149
(0:034) (0:032) (0:031) (0:032) (0:041) (0:041) (0:039) (0:041) (0:041)
african / colored  0:432  0:423  0:420  0:422  0:411  0:324  0:310  0:315
(0:054) (0:054) (0:055) (0:056) (0:056) (0:053) (0:054) (0:054)
white / other  0:080  0:096  0:103 0:087 0:092 0:086 0:088 0:082
(0:086) (0:089) (0:088) (0:079) (0:079) (0:074) (0:078) (0:078)
age / 10  0:391  0:397  0:387  0:384  0:416  0:323  0:316  0:321
(0:091) (0:094) (0:094) (0:095) (0:101) (0:101) (0:102) (0:100)
(age / 10)2 0:050 0:050 0:049 0:049 0:052 0:041 0:038 0:039
(0:011) (0:012) (0:012) (0:012) (0:012) (0:012) (0:012) (0:012)
BMI / 10  0:036  0:030  0:030  0:033  0:034  0:039  0:040  0:039
(0:021) (0:020) (0:021) (0:021) (0:021) (0:020) (0:019) (0:019)
number of bf gf  0:020  0:020  0:020  0:020  0:006 0:001  0:001  0:003
(0:013) (0:013) (0:013) (0:013) (0:020) (0:019) (0:019) (0:019)
higher primary  0:005  0:004  0:008  0:024  0:019  0:021
(0:035) (0:035) (0:035) (0:035) (0:036) (0:035)
high school 0:014 0:015 0:010  0:003  0:024  0:031
(0:039) (0:039) (0:039) (0:039) (0:039) (0:039)
tertiary education 0:029 0:039 0:020  0:007  0:097  0:087
(0:174) (0:174) (0:176) (0:177) (0:181) (0:185)
arm (optout) * african / coloured  0:063  0:060  0:065  0:036  0:042
(0:157) (0:156) (0:146) (0:146) (0:146)
arm (optout) * white / other 0:103 0:112 0:087 0:128 0:114
(0:248) (0:247) (0:232) (0:237) (0:236)
arm (assess) * african / coloured 0:065 0:065 0:054 0:064 0:074
(0:138) (0:137) (0:130) (0:130) (0:131)
arm (assess) * white / other 0:267 0:271 0:253 0:261 0:257
(0:198) (0:197) (0:186) (0:189) (0:190)
arm (supp) * african / coloured  0:050  0:048  0:056  0:048  0:052
(0:152) (0:152) (0:140) (0:141) (0:140)
arm (supp) * white / other 1:095 1:088 1:001 0:984 0:965
(0:198) (0:198) (0:186) (0:190) (0:189)
multiple partners  0:007 0:002  0:000 0:006
(0:037) (0:036) (0:036) (0:036)
other partners 0:061 0:045 0:044 0:040
(0:048) (0:047) (0:047) (0:048)
single  0:059  0:039  0:032  0:032
(0:034) (0:033) (0:033) (0:034)
STD times  0:007  0:005  0:004  0:003
(0:012) (0:015) (0:015) (0:016)
STI screen  0:011 0:002 0:002 0:004
(0:015) (0:016) (0:017) (0:017)
TB screen  0:005  0:003  0:003  0:004
(0:007) (0:007) (0:007) (0:007)
subjective probability  0:259  0:259  0:260
(0:047) (0:046) (0:046)
days since HCT began / 100 0:115 0:098
(0:343) (0:346)
(days since HCT began / 100)2  0:084  0:075
(0:143) (0:145)
hourly paid workers  0:039  0:034
(0:028) (0:028)
years at Company 0:001 0:001
(0:002) (0:002)
HCT before 0:056
(0:025)
nurse no no yes yes yes yes yes yes yes
pseudo R2 0:004 0:112 0:13 0:13 0:133 0:139 0:166 0:173 0:176
n 1404 1387 1387 1382 1382 1377 1294 1274 1274
Notes 1. Cluster robust standard errors in parenthesis. Clusters are nurse  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. MSP sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
6. Nurse fixed eects are used in place of area fixed eects.
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Table A10: Uptake Probit, HCT Sample, Marginal Effects, Nurse Fixed Effects
.
.
.
covariates (1) (2) (3) (4) (5) (6) (7) (8) (9)
(Intercept) 0:196 0:599 0:998 1:015 1:016 1:066 1:036 0:950 0:951
(0:022) (0:147) (0:163) (0:151) (0:149) (0:156) (0:153) (0:179) (0:181)
arm (optout)  0:003 0:002  0:005  0:005 0:008 0:011 0:009 0:011 0:011
(0:022) (0:022) (0:021) (0:021) (0:021) (0:020) (0:021) (0:021) (0:021)
arm (assess)  0:014  0:007  0:007  0:009  0:009  0:009  0:009  0:006  0:007
(0:019) (0:019) (0:017) (0:018) (0:017) (0:018) (0:018) (0:018) (0:018)
arm (supp)  0:013  0:008  0:013  0:012  0:010  0:013  0:014  0:018  0:018
(0:020) (0:020) (0:019) (0:019) (0:018) (0:018) (0:018) (0:022) (0:021)
african / colored  0:080  0:087  0:091  0:089  0:083  0:055  0:056  0:055
(0:020) (0:019) (0:018) (0:019) (0:019) (0:018) (0:019) (0:019)
white / other  0:052  0:050  0:044  0:020  0:016  0:013  0:006  0:006
(0:026) (0:025) (0:024) (0:026) (0:026) (0:024) (0:023) (0:023)
age / 10  0:190  0:166  0:156  0:165  0:196  0:175  0:175  0:173
(0:073) (0:075) (0:072) (0:073) (0:078) (0:074) (0:080) (0:081)
(age / 10)2 0:024 0:021 0:019 0:020 0:023 0:020 0:019 0:018
(0:010) (0:010) (0:010) (0:010) (0:011) (0:010) (0:010) (0:011)
BMI / 10  0:015  0:007  0:007  0:008  0:003 0:003 0:004 0:004
(0:012) (0:012) (0:012) (0:012) (0:011) (0:012) (0:011) (0:011)
number of bf gf 0:007 0:007 0:008 0:008  0:000 0:003 0:004 0:004
(0:006) (0:006) (0:006) (0:006) (0:007) (0:008) (0:007) (0:007)
higher primary  0:047  0:050  0:043  0:031  0:020  0:020
(0:038) (0:036) (0:035) (0:032) (0:034) (0:035)
high school  0:023  0:028  0:024  0:012 0:003 0:003
(0:038) (0:036) (0:034) (0:032) (0:035) (0:036)
tertiary education  0:031  0:031  0:022  0:015 0:003 0:004
(0:043) (0:041) (0:039) (0:035) (0:040) (0:040)
master’s degree  0:113  0:114  0:114  0:105  0:090  0:089
(0:056) (0:055) (0:056) (0:051) (0:052) (0:052)
arm (optout) * african / coloured  0:030  0:010  0:012  0:009  0:008
(0:055) (0:053) (0:049) (0:050) (0:050)
arm (optout) * white / other  0:142  0:127  0:122  0:120  0:119
(0:064) (0:064) (0:059) (0:059) (0:059)
arm (assess) * african / coloured  0:013  0:005  0:043  0:039  0:038
(0:046) (0:046) (0:043) (0:044) (0:044)
arm (assess) * white / other  0:047  0:043  0:068  0:072  0:072
(0:068) (0:068) (0:062) (0:061) (0:061)
arm (supp) * african / coloured  0:036  0:028  0:035  0:028  0:029
(0:048) (0:048) (0:044) (0:045) (0:045)
arm (supp) * white / other 0:008 0:015 0:008 0:009 0:010
(0:068) (0:070) (0:064) (0:063) (0:063)
multiple partners 0:062 0:055 0:051 0:050
(0:024) (0:029) (0:028) (0:028)
other partners  0:009  0:007  0:008  0:008
(0:028) (0:028) (0:029) (0:029)
single  0:033  0:024  0:025  0:025
(0:016) (0:016) (0:016) (0:016)
STD times  0:011  0:006  0:007  0:007
(0:005) (0:005) (0:005) (0:005)
STI screen  0:003  0:002  0:004  0:004
(0:007) (0:007) (0:007) (0:007)
TB screen  0:005  0:004  0:003  0:003
(0:005) (0:005) (0:005) (0:005)
subjective probability  0:144  0:143  0:142
(0:027) (0:027) (0:027)
days since HCT began / 100 0:094 0:096
(0:204) (0:202)
(days since HCT began / 100)2  0:036  0:037
(0:085) (0:085)
hourly paid workers 0:023 0:022
(0:019) (0:019)
years at Company 0:002 0:002
(0:001) (0:001)
HCT before  0:008
(0:016)
nurse no no yes yes yes yes yes yes yes
pseudo R2 0:001 0:067 0:147 0:161 0:178 0:206 0:27 0:276 0:277
n 1318 1315 1313 1308 1308 1306 1246 1231 1231
Notes 1. Cluster robust standard errors in parenthesis. Clusters are nurse  date.
2. , , indicate statistical significance at 10%, 5%, 1% levels, respectively.
3. Estimates show marginal impacts on uptake probabilities computed with @p@xi j =
nP
i=1
(0xi) j
n . Standard
errors are derived with delta method.
4. Default ethnicity category is Indians. All interaction terms are demeaned. area indicates the use of
area fixed eects.
5. HCT sample only. Sample dropped plausibly knowing HIV infected individuals who are not tested but
answers “know about my status”, tested positive in prevalence study, and own subjective probability
of infection is 1.
6. Nurse fixed eects are used in place of area fixed eects.
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Figure A1: Coefficient of Variations of Uptake by Nurse and Ethnicity
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Notes 1.Coecient of variations in uptake by nurse-ethnicity combination.
2.Nurses-ethnicity with less than 20 subjects are discarded due to small sample.
F Organizational concerns
Company consists of three layers of employees; executives, salaried employees, and hourly paid
employees. By the job type, former two correspond to administrative positions, and the hourly paid
employees are production employees. In a manufacturing firm, HIV testing has an immediate impact
on production, because it takes employees away from the production line.
In each production area, a daily production target is given. If there is a testing, general managers
(GMs) of areas must organize a plan to substitute the employees that are taken o from the pro-
duction line. Some areas are chronically short of employees, and have faced a greater diculty in
releasing employees for testing. We have asked each area GMs to accommodate testing, and allo-
cated dates that will not interfere with their daily production targets. GMs assigned coordinators
from their area to manage the employee movements while maintaining production flows.
Even when the GMs can figure out the plans, production is subject to demand changes and supplier
shocks, so daily production target varies by day and may not be foreseen well in advance. This makes
it dicult to share a definitive plan for HIV testing with the health care providers. For example, there
were major strikes by the port and public transportation employees in 2010 which put an enormous
strain on production line, and have resulted in reducing the number of employees who can be taken
o. In light o this, we have tried to diversify the burden and risks by bunching neighboring areas.
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When one area faces unforeseen employee shortage, as they often do, the neighboring area is asked
to release extra employees, so the employee release target is achieved.
While we received an approval to run the interventions from CEO at the onset, we still had to
get an approval from the board members. Company Health Services and IDE research team have
formed a task force to plan the interventions. The task force drafted intervention plans that are seam-
lessly connected with existing infrastructure and health programs, and explained them repeatedly to
managerial personnel.
The task force has asked the trade unions to work with us to accommodate and promote testing.
We received supports from their representatives right from the beginning. Shop stewards (union rep-
resentatives) were particularly concerned with confidentiality of testing and equal treatment among
their member employees, which we promised to maintain.
From KAPB study, we knew that Company Health Services has a reputation of keeping individual
information confidential. We confirmed with lawyers that Company MS maintains the privilege to
record the HIV related information of all employees, so we can ask names and oer a test, but at
the same time Company MS is bound by doctor-patient privilege and will be legally punished if
information is submitted to any other personnel inside and outside of Company. So all information
related to individual identity is stripped by Company MS before we receive the data set.
In a hope to boost the uptake in short period of time, Company hired EAP service providers to
implement the interventions. Through them, Company hired nurses and receptionists. Company
also leased in mobile clinic units and other equipments. IDE research team has provided protocols
and other documentations. Data was captured by EAP and information related to individual identity
was deleted by Company MS before being sent to IDE research team.
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